final_programme - Österreichische Gesellschaft für Allergologie

Transcription

Österreichische Gesellschaft für Allergologie und Immunologie
&
Deutsche Gesellschaft für Immunologie
JOINT ANNUAL MEETING
OF IMMUNOLOGY
OF THE
AUSTRIAN AND GERMAN SOCIETIES
Lecture Centre of the Vienna General Hospital
Vienna, Austria
Wednesday, September 3 – Saturday, September 6, 2008
Final Programme
www.medacad.org/oegai2008
ALLERGIE LAUF
Sonntag, 7. September 2008
Schlosspark Schönbrunn
Hiermit laden wir Sie ganz herzlich dazu ein, im Anschluss an den Kongress
„Joint Annual Meeting of Immunology, Wien, 3.-6. September 2008“, am
ALLERGIE LAUF am Sonntag, 7. September 2008
im SCHLOSSPARK SCHÖNBRUNN,
einer der schönsten Parkanlagen Wiens, teilzunehmen.
Nach dem Startschuss von Nobelpreisträger Peter Doherty geht es durch den Schlosspark Schönbrunn,
durch Alleen mit barocker Gartenbaukunst, und vorbei am Schloss Schönbrunn, einem der bedeutendsten
Kulturdenkmäler Österreichs, einst bewohnt von Kaiserin Sissi und heute ein beliebtes Ausflugsziel vieler
Wiener und Wienbesucher.
Sie können unter verschiedenen Distanzen wählen und auch im Team laufen. Das Tempo bleibt Ihnen
überlassen: gemütlich oder mit sportlichem Ehrgeiz, dazu wird es eine exakte elektronische Zeitmessung
geben. Ob Kongressteilnehmer oder nicht - es sind alle eingeladen, mit zu laufen.
Im Anschluss an den Lauf folgen als Krönung des Tages und als Belohnung für Ihren sportlichen Einsatz
und das tüchtige anfeuern Ihrer Fans, die After Running Party, die Siegerehrung, eine Tombola, ein
Buffet reich an köstlichen typisch österreichischen Gerichten, und eine Musikshow. Es unterhalten
Sie Harry Sonnek und der legendäre Dave Dee, der mit seinen besten Songs aus den 60ern aus London
zu uns kommen wird und für die richtige Partystimmung sorgen wird. Zur After Running Party sind alle
Läufer und deren Begleiter ganz herzlich eingeladen.
Bitte nutzen Sie die Möglichkeit der Online-Anmeldung auf www.medacad.org/oegai2008 unter „Allergy
Run“ sobald als möglich, damit Sie sich Ihr, in der Gebühr inkludiertes, Erinnerungs- T-Shirt in der
richtigen Größe sichern.
Auf der Homepage finden Sie auch alle mit dem Lauf verbundenen Informationen, sowie den vorläufigen
Streckenplan.
Wir freuen uns auf zahlreiche Anmeldungen!
www.bundesgaerten.at
Österreichische Gesellschaft für Allergologie und Immunologie
&
Deutsche Gesellschaft für Immunologie
JOINT ANNUAL MEETING
OF IMMUNOLOGY
OF THE
AUSTRIAN AND GERMAN SOCIETIES
Vienna, Austria
Wednesday, September 3 – Saturday, September 6, 2008
Final Programme
www.medacad.org/oegai2008
Table of Contents
1
General
Patronage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Welcome Addresses
......................................................... 3
Committees – Board – Organisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Programme at a Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Scientific Programme
- Wednesday, September 3, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
- Thursday, September 4, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
- Friday, September 5, 2008
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
- Saturday, September 6, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Poster Viewing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Business Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Satellite Lunch Symposia
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Information on Posters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Information for Speakers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Information
Congress Information
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Registration Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Venue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Social Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
City Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
Exhibition
Exhibition – General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
List of Sponsors, Exhibitors and Advertisers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Patronage
2
Under the Patronage of
Dr. Alfred Gusenbauer
Federal Chancellor of the Federal Republic of Austria
Dr. Johannes Hahn
Federal Minister for Science and Research
Dr. Andrea Kdolsky
Federal Minister for Health, Family and Youth
Mag. Sonja Wehsely
Executive City Councillor for Public Health and Social Affairs
Acknowledgements
The Joint Annual Meeting of Immunology gratefully acknowledges the support of the following
institutions, companies and organisations (list correct as per date of printing):
Welcoming Addresses
3
Unquestionably a high level of health care is the core element of our modern
welfare system as we know it. It is therefore our duty as politicians to secure
the basis for its long-term financial stability. Furthermore, we must create an
institutional and legal framework to guarantee universal and non-discriminatory access to all forms of treatment. Nobody should be excluded or left
behind. Only under these conditions can health-care professionals fulfil their
essential duty and live up to their oath i.e. helping people.
Public opinion polls show the high satisfaction of Austrians with our national
health care system. But no society can satisfy itself with self appreciation. Many challenges lie
ahead of us. Some are institutional, financial, others are scientific. This congress will help to promote knowledge and hopefully inspire all working in your field.
On behalf of the Austrian government it is my pleasure to welcome you here in Austria and in
particular at this “Joint Annual Meeting of Immunology”.
Dr. Alfred Gusenbauer
Federal Chancellor of the Federal Republic of Austria
More than 1000 participants at the „Joint Annual Meeting of lmmunology"
give invigorating proof of the importance and international reputation of the
Societies of Allergology and Immunology in Austria and Germany on the one
hand and the Vienna Medical Academy in the fields of education/research as
well as conference and association management – an organisation dedicated
to serving the needs of the medical non-profit community - on the other. As
minister of Science and Research it is good news for me that international
experts are discussing such pressing topics as vaccination, infection and
allergy just now in Austria. That means new incentives for the Scientific Community especially in our country and the opportunity to expand international networking. These
issues are of great relevance for nearly all of us and the expectations are very high, if you only think
of tumor immunology for example. May the meeting be a successful one with impressing results
and congratulations on bringing together university professors of international reputation in this
field in Vienna for the first time. In this way the meeting is a great recognition of Vienna as an important medical research place.
Dr. Johannes Hahn
Federal Minister for Science and Research
Welcoming Addresses
4
Dear colleagues and scientific friends,
It is our great pleasure to welcome you to the Joint Annual Meeting of the Austrian and the German Societies of Immunology in Vienna.
The annual conferences of our societies allow for an exchange of thoughts and information on cutting edge developments taking place in the immunological laboratories worldwide. The format of
a joint annual conference allows for an expansion of this exchange into a neighbouring country
and likewise fosters new and/or permits to renew longstanding scientific and social relationships.
With this meeting we are aiming to delineate the latest progress in our field, focusing on matters
arising not only in basic innate and adaptive immunity, but also clinical immunology including
novel therapeutic approaches. The scientific committee has invited outstanding scientists to present their thinking and to summarize data on their advances in plenary sessions and introductions
to workshops. Within workshops and during the poster sessions, there will be ample opportunity
especially for students and postdoctoral fellows to present their newest research results and thus
a broad array of work which is performed in the realm of the hosting societies and beyond.
We have made all efforts to create a scientific program that meets your expectations. In addition
you shall enjoy Vienna´s ambience and hospitality, the unique culture and spirit which so few
other cities have to offer.
With best wishes for a scientifically exciting and
stimulating meeting and
mit herzlichen Grüßen,
Yours
Stefan Meuer & Josef Smolen
Committees – Board – Organisation
Congress Committee
Stefan C.W. Meuer
Andreas Radbruch
Reinhold E. Schmidt
Josef Smolen
Marcus Säemann
Local Organising Committee
Irmgard Förster
Beatrix Grubeck-Loebenstein
Erika Jensen-Jarolim
Stefan C.W. Meuer
Winfried Pickl
Andreas Radbruch
Marcus Säemann
Reinhold Schmidt
Josef Smolen
Hannes Stockinger
Rudolf Valenta
Gerhard Zlabinger
ÖGAI Executive Committee
Josef Smolen (President)
Rudolf Valenta (President Elect)
Beatrix Grubeck-Loebenstein (Past President)
Marcus Säemann (Secretary General)
Winfried Pickl (Deputy Secretary)
Tamara Kopp (Secretary Protocol)
Barbara Bohle (Treasurer)
Gernot Achatz (Board Member)
Hans-Peter Brezinsek (Board Member)
Roswitha Gruber-Sgonc (Board Member)
Erika Jensen-Jarolim (Board Member)
Johannes Stöckl (Board Member)
Martin Thurnher (Board Member)
Othmar Förster (Honorary President)
DGfI Executive Committee
Stefan C.W. Meuer (President)
Andreas Radbruch (President Elect)
Reinhold E. Schmidt (Past President)
Werner Solbach (Secretary General)
Christian Bogdan (Board Member)
Barbara Bröker (Board Member)
Stefan Ehlers (Board Member)
Irmgard Förster (Board Member)
Reinhold Förster (Board Member)
Stefan H. E. Kaufmann (Board Member)
Heidrun Moll (Board Member)
Yvonne Samstag (Board Member)
Burkhart Schraven (Board Member)
Hans Dieter Volk (Board Member)
Hans-Martin Jäck (Board Member)
Conference Organisation, Abstract Management, Sponsoring
Vienna Medical Academy
Ms. Marieke Hodel
Alser Strasse 4, 1090 Vienna, Austria
Phone: +43 1 405 1383-10; Fax: +43 1 407 8274
E-mail: [email protected]
Exhibition Management
Hotel Accomodation
Medizinische Ausstellungs- und
Werbegesellschaft MAW
Freyung 6
A-1010 Vienna, Austria
Phone: +43 1 536 630
Fax: +43 1 535 60 16
E-mail: [email protected]
Mondial Congress & Events
Operngasse 20b
1040 Vienna
Phone: +43 1 58804-0
Fax: +43 1 58804-185
Email: [email protected]
Congress Venue
(Allgemeines Krankenhaus - AKH)
Währinger Gürtel 18-20
1090 Vienna, Austria
5
Workshops
Parallel Symposium 2:
In vivo imaging
Vaccination
Parallel Symposium
Vaccines & Adjuvants
Autoimmunity I
NK cells
Immunomodulation
Lecture Hall 4
Welcome Reception at the Vienna City Hall
Immunomodulation
Break & Poster Viewing
Signal Transduction
Tumor Immunology
Tumor Immunology
Lecture Hall 3
Satellite Lunch Symposium
Lecture Hall 2
Innate Immunity: Antigen-PresentingCells
T-Lymphocytes II
Satellite Lunch Symposium:
B cell: Promising target in autoimmune diseases (Roche)
Plenary Session
19.00
14.00 –
15.30
15.30 –
16.30
16.45 –
18.00
12.15 –
13.45
T-Lymphocytes I
T-Cell Signaling
08.15 –
09.30
09.30 –
10.30
10.30 –
12.15
Lecture Hall 1
Time
Thursday, September 4, 2008
Followed by Welcome Drinks
Opening by Wolfgang Schütz (Rector of the Medical University of Vienna)
Vienna Philharmonic
Keynote Lecture: Nobel Laureate Peter Doherty
Vienna Philharmonic
Awarding of the Landsteiner Medal of the ÖGAI to Ron Germain
Awarding of the Landsteiner Price of the DGfI to Max Cooper
Karl Landsteiner (1868-1943) - An Austrian Immuno-Pathologist (G. Schmidt-Wyklicky)
Welcome and Opening
Stefan Meuer, President DGfI
Josef Smolen, President ÖGAI
15.00 –
15.10
15.10 –
15.25
15.25 –
15.45
15.45 –
16.05
16.05 –
16.20
16.20 –
16.50
16.50 –
17.00
17.00 –
17.15
Lecture Hall 1
Time
Wednesday, September 3, 2008
Programme at a Glance
Veterinary Immunology
Innate Immunity: Antigen-Presenting
Cells
Lecture Hall 5
6
Regulatory Lymphocytes I
Allergy I
Parallel Symposium
Best Poster Awards
Klinische Fälle aus der Allergologie:
Wie hätten Sie entschieden?
Workshops
General Assembly ÖGAI
Autoimmunity II
Vom rekombinanten Allergen zu
neuen Allergietherapien (Phadia)
Break
Lecture Hall 2
Inflammation
Lecture Hall 1
Autoimmunity
Plenary Session
Time
08.45 –
10.00
10.00 –
10.30
10.30 –
12.15
12.15 –
12.45
12.45 –
13.00
13.00 –
13.45
14.00 –
14.30
15.00
Adaptive Immunity: B-Cells
Regulatory Lymphocytes II
Alloimmunity & Tolerance
Lecture Hall 3
Transplantation
Mucosal Immunity
Pattern Recognition Receptors &
Myeloid Cells
Lecture Hall 4
Satellite Lunch Symposium
Infection II
Break
Lecture Hall 3
Allergy
Break
Complement System
Lecture Hall 4
Departure with buses to the Viennese “Heuriger” Fuhrgassl-Huber
Adaptive Immunity: Regulation
Infection
General Assembly DGfI
Allergy II
Infection I
Immune modulation with intravenous
Drittmittelförderung der DFG: Kriterien immunoglobulin: the established and
the advances (Octapharma)
für eine erfolgreiche Antragstellung
Lecture Hall 2
Mucosal Inflammation
Lecture Hall 1
Innate Immunity: Regulation
Saturday, September 6, 2008
Time
08.15 –
09.30
09.30 –
10.30
10.30 –
12.15
12.15 –
13.00
13.00 –
13.45
14.00 –
15.30
15.30 –
16.30
16.45 –
18.00
18.00 –
19.30
19.30
Friday, September 5, 2008
Programme at a Glance
Cytokines, Chemokines & their
receptors
Lecture Hall 5
B-Lymphocytes
Lecture Hall 5
7
Scientific Programme – Wednesday, September 3, 2008
Time
Lecture Hall 1
15.00
15.10
Welcome
Chair: S. Meuer, J. Smolen
Welcoming addresses by
Stefan Meuer, President DGfI
Josef Smolen, President ÖGAI
15.10
15.25
Karl Landsteiner (1868-1943) - An Austrian Immuno-Pathologist
Gabriela Schmidt-Wyklicky
15.25
15.45
Awarding of the Landsteiner Price of the DGfI to Max Cooper
Laudatio: Andreas Radbruch
Award Lecture: Max Cooper
15.45
16.05
Awarding of the Landsteiner Medal of the ÖGAI to Ron Germain
Laudatio: Clemens Scheinecker
Award Lecture: Ron Germain
16.05
16.20
Rainer Honeck, Concert Master of the The Vienna Philharmonic Orchestra: J.S. Bach
16.20
16.50
Keynote Lecture:
Nobel laureate Peter Doherty
16.50
17.00
Rainer Honeck, Concert Master of the Vienna Philharmonic Orchestra: F. Kreisler
17.00
17.15
Opening by Wolfgang Schütz (Rector of the Medical University of Vienna)
17.15
Welcome Drinks
8
Scientific Programme – Thursday, September 4, 2008
Time
08.15
09.30
09.30
10.30
Lecture Hall 1
Lecture Hall 2
9
Lecture Hall 3
T-Cell Signaling
Chair: W. Pickl, D. Kabelitz
Innate Immunity: Antigen-PresentingCells
Chair: G. Stingl, B. Broeker
Tumor Immunology
Chair: E. Jensen-Jarolim, G. Riethmüller
Molecular determinants of Inside-out
signaling in T-cells
B. Schraven
DC dependent maintenance of peripheral
regulatory T-cells
S. Beissert
Human Self/Tumor Antigens and Tumor
Immunosurveillance
O.J. Finn
From T cell activation signals to signaling
control of anti-cancer immunity
J. Penninger
Role of antimicrobial peptides in triggering The immune response to sporadic cancer
autoimmunity
T. Blankenstein
M. Gilliet
Deciphering TCR ligand discrimination by
combining experiments, computer
modeling, and predictive simulations
R. Germain
TLR-activated dendritic cells as effector
cells of the immune response
G. Stingl
Coffee Break / Poster Viewing / Exhibition
Development of DNA vaccination strategies for pediatric cancers
H.N. Lode
Time
10.30
12.15
Lecture Hall 1
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
10
Lecture Hall 5
T-Lymphocytes I
Chair: G. Schütz,
H. Wolf
Autoimmunity I
Chair: H. Strobl,
G. Beilhack
Tumor Immunology
Chair: J. Singer,
T. Weichhart
Immunomodulation
Chair: K. Loser,
W. Berger
Innate Immunity: Antigen-Presenting Cells
Chair: N. Romani,
H. Schild
1. Increased Th17 and
decreased CD4+FoxP3+
T regulatory cells in third
trimester pregnancies
with pre-eclampsia
B. Santner-Nanan,
M. Peek, L. Richarts,
R. Khanam, E. Zhu, B.
Fazekas de St. Groth,
R. K. Nanan
9. The role of B cells in
tissue draining lymphnodes for the development of collagen
induced arthritis (CIA)
C. Scheinecker,
A. Rapp, M. Bonelli,
A. Savitskaya,
J. S. Smolen
17. Higher avidity of
TCR-gene-modified T
cells by using parts of
the murine constant TCR
regions
D. Sommermeyer,
W. Uckert
25. Regulation of homing
receptor expression in
CD4+ T cells
B. A. Ratsch, C. Doebis,
S. Jennrich, S. Floess,
A. Hamann, U. Syrbe
33. Targeting of
Haemagglutinin antigen
to C-type Lectins on
human Dendritic Cells
elicits different T cell responses in vitro
G. F. Heidkamp,
F. Nimmerjahn,
A. Piperno, H. Zebroski,
R. M. Steinman,
M. C. Nussenzweig,
D. Dudziak
2. Blockade of inducible
costimulator (ICOS) inhibits accumulation of
polyfunctional
Th1/Th17cCells and prevents autoimmune arthritis
O. Frey, J. Meisel,
L. Bruns, A. Hutloff,
L. Morawietz, T. Kamradt
10. T helper cells only induce acute inflammation
but B cells are necessary
for the induction of
chronic Antigen-induced
Arthritis
M. Janke, T. Hohnstein,
L. Morawietz,
A. Scheffold
18. Reprogramming T
cells to become MHC independent - electroporation of RNA encoding
chimeric antigen receptors
N. Schaft, T. Schunder,
C. Krug, S. Reuter,
D. Kosmides, H. Abken,
M. Kershaw,
E. Kämpgen, G. Schuler,
J. Dörrie
26. Regulated release
and functional modulation of junctional adhesion molecule A by
disintegrin metalloproteinases
J. Pruessmeyer,
R. Koenen, L. Fraemohs,
O. Soehnlein, C. Weber,
A. Ludwig
34. PPARgamma enhances uptake and
cross-presentation of
soluble antigen in dendritic cells
S. Hucke, J. Floßdorf,
I. Dani, D. Thimm,
A. Kautz, C. Kurts,
P. Knolle, L. Klotz,
S. Burgdorf
3. IRF4 is essential for
IL-21-mediated induction, amplification and
stabilization of the Th17
phenotype
M. Huber, A. Brüstle,
A. Guralnik, A. Mahiny,
E. von Löw, M. Lohoff
11. Crucial role of CCR4
in the development of
experimental CNS autoimmune disease by
modulation of Treg cell
compartimentalization
J. Alferink, D. M. Otte,
K. Poppensieker,
Ö. Yilmaz, A. Mildner,
M. Prinz, W. Maier,
A. Zimmer
19. Memory CD8+ T-cell
mediated tumor rejection
is impaired in NKG2Ddysfunctional mice
M. C. Banerjea,
D. Sigurdardottir,
B. Pömmerl,
H. Rammensee,
A. Steinle
27. Ontogeny of Langerhans cells in prenatal
human skin
C. Schuster, C. Vaculik,
C. Fiala, W. Eppel,
S. Meindl, M. Imhof,
A. Elbe-Bürger
35. Genomic RNA of
human rhinovirus - a
”semi-danger-signal” for
dendritic cells
C. Schrauf,
S. Kirchberger,
O. Majdic, J. Seipelt,
J. Stöckl
4. Acid sphingomyelinase is a critical regulator of cytotoxic granule
secretion by primary T
lymphocytes
J. Herz, J. Pardo,
H. Kashkar,
M. Schramm,
E. Kuzmenkina, E. Bos,
K. Wiegmann,
R. Wallich, P. J. Peters,
S. Herzig, E. Schmelzer,
M. Krönke, M. M. Simon,
O. Utermöhlen
12. Antigen-specific
TGF -induced Treg suppress Th17-mediated
autoimmune disease
E. N. Huter,
G. H. Stummvoll,
E. M. Shevach
20. Rejection of established cancer: Lack of
IFN- , TNF- and Fas-ligand but not perforin by
effector CD8+ T cells allows cancer to progress
J. J. Listopad,
G. Willimsky,
B. Silkenstedt,
T. Kammertöns,
T. Blankenstein
28. Requirement of
CCL17 for progression
of atopic dermatitis and
contact hypersensitivity
in mice
S. Stutte, N. Gerbitzki,
I. Förster
36. Antagonism between
GATA-1 and vitamin D3
receptor in myelopoisis
and dendritic cell subset
differentiation
S. Taschner-Mandl,
F. Göbel, M. Kumerz,
J. Jurkin, C. Vaculik,
S. Richter, C.
Bieglmayer,
A. Elbe-Bürger,
H. Strobl
5. Adenosine regulates
CD8 T cell priming by inhibition of membraneproximal T cell receptor
signaling
D. Stabenow,
C. Linnemann,
F. A. Schildberg,
A. Schurich,
S. I. Hegenbarth,
L. Diehl, E. Endl,
S. Lacher, C. E. Müller,
J. Frey, L. Simeoni,
L. Simeoni, B. Schraven,
P. A. Knolle
13. The pathogenic role
of HnRNP-A2 in Pristane-induced arthritis
M. H. Hoffmann, C.
Baumann, B. Meyer,
G. Steiner
21. Defects of the antigen processing machinery leading to T cell
resistance of melanoma
cells
M. Keller, F. Ebstein,
A. Paschen, E. Bürger,
D. Schadendorf,
P. M. Kloetzel,
U. Seifert
29. Acid sphingomyelinase is required for efficient phago-lysosomal
fusion
M. Schramm, U. Karow,
A. Haas, M. Krönke,
O. Utermöhlen
37. Function of hypoxiainducible factor (HIF)-1
in dendritic cells
T. Köhler,
R. S. Johnson,
H. Weighardt, I. Förster
6. pSMAC formation in
human peripheral blood
T-cells requires localization of the actin-bundling
protein L-plastin to the
immunological synapse
G. Wabnitz, P. Lohneis,
H. Kirchgessner,
Y. Samstag
14. The autoimmune regulator Roquin-a cofactor
for miRNA function?
E. Glasmacher,
K. P. Höfig, E. Kremmer,
V. Heissmeyer
22. Tumor-specific T
helper cells regulate
tumor dormancy or
progress multistage carcinogenesis through T
cell cytokines
H. Braumueller,
T. Wieder, N. Bauer,
M. Rocken
30. Phenotypic and molecular analysis of an
HLA Class II deficient
patient reveals a homozygous nonsense
mutation in the CIITA
gene at amino acid position 381
K. G. Schmetterer,
M. G. Seidel,
U. Körmöczi,
K. Schwarz, S. MatthesMartin, P. Steinberger,
W. F. Pickl
38. Distinct mechanism
of antigen routing and
cross-presentation in
LSEC
A. K. Schurich,
J. Böttcher, S. Burgdorf,
P. Penzler,
S. Hegenbarth,
D. Stabenow, A. Dolf,
E. Endl, C. Kurts,
P. A. Knolle
Scientific Programme – Thursday, September 4, 2008 (continued) 11
Lecture Hall 1
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
Lecture Hall 5
7. The effect of thymectomy in early childhood
on the naive T cell compartment in later life
M. Prelog, M. Keller,
R. Geiger, A. Brandstaetter, R. Würzner,
B. Grubeck-Loebenstein,
L. B. Zimmerhackl
15. OSCAR, a key costimulation molecule for
osteoclasts, is induced
in patients with rheumatoid arthritis
S. Herman, G. Krönke,
R. Müller, J. Zwerina,
K. Redlich, G. Schett
23. Identification of
tumor antigens using antibodies induced by dendritic cell (DC) based
vaccines
J. Leitner, A. Stift,
J. Friedl, R. Pfranger,
P. Steinberger,
K. Pfistershammer
31. Different mechanisms of immunosuppression caused by
Cyclosporine A (CsA)
and FK506
T. Giese, C. Sommerer,
C. Jacobi, M. Zeier,
S. Meuer
39. Skin dendritic cells
present lipid antigens to
natural killer T cells
P. Stoitzner,
I. F. Hermans,
N. Romani
8. Clonal evolution of the 16. Imaging immuneeffector T cell repertoire neuronal interactions in
D. Zehn, M. J. Bevan
experimental autoimmune encephalomyelitis using intravital
two-photon microscopy
V. Siffrin, J. Herz,
T. Leuenberger,
A. U. Brandt,
H. Radbruch, R. Niesner,
C. Infante-Duarte,
F. Zipp
24. Serological relationship between cutaneous
human papillomavirus
types 5, 8 and 92
A. Handisurya,
C. Schellenbacher,
R. Gambhira,
S. Shafti-Keramat,
O. Forslund, M. Favre,
R. Kirnbauer
32. Identification of three
novel genes as
biomarker for monitoring
anti-TGFbeta therapy
S. Classen, C. Muth,
D. Eggle, M. Beyer,
T. Zander,
A. Staratschek-Jox,
J. L. Schultze
Time
Lecture Hall 1
12.15
13.45
Satellite Lunch Symposium - Roche
B cell: Promising target in autoimmune diseases
Chair: J. Smolen
The biology of the B cell in autoimmune diseases
A. Radbruch
Clinical experiences with B cell therapies
T. Dörner
Safety: Experiences with Rituximab
H-P. Brezinsek
Time
14.00
15.30
Lecture Hall 1
Lecture Hall 4
12
Lecture Hall 2
Lecture Hall 3
Lecture Hall 5
T-Lymphocytes II
Chair: M. Lohoff,
A. Thiel
Chair: B. Grubeck,
S. Weiss
Signal Transduction
Chair: T. Bürckstürmer,
T. Stulnig
NK cells
Chair: C. Watzl,
M. Fischer
Chair: A. Saalmüller,
M. Müller
40. Stability and flexibility of CD4 T cell differentiation programs in vitro
and in vivo
A. N. Hegazy,
H. Hengartner,
R. M. Zinkernagel,
A. Radbruch,
M. Löhning
48. Improvement of the
Immunogenicity of a
HIV-1 Clade C Candidate Vaccine increasing
Gag, Pol, Nef and Env
Specific T-Cell Responses
J. Wild, J. Koestler,
S. Bredl, K. Boeckl,
R. Wagner
56. Oxidation of cofilin
mediates T cell hyporesponsiveness under oxidative stress conditions
M. Klemke, G. Wabnitz,
F. Funke, B. Funk,
H. Kirchgessner,
Y. Samstag
64. The stress-inducible
endogenous danger signals HSP70 and MICA
synergistically activate
the cytotoxic effector
functions of human NK cells
L. Elsner, P. F. Flügge,
J. Lozano, V. Muppala,
S. Y. Demiroglu,
D. Malzahn, H. Bickeböller,
G. Multhoff, L. Walter,
R. Dressel
72. Charakterization of
the chicken CD40CD40L system unsing
the RCAS retroviral gene
transfer technology
K. Schenk-Weibhauser,
J. Young, B. Kaspers,
S. Kothlow
41. On the role of
adipokines in Th2 lymphocyte polarization
A. Batra, B. Okur, J.
Ihbe, T. Stroh,
R. Glauben, I. Fedke,
M. Zeitz, B. Siegmund
49. Safety and immunogenicity in a phase I
dose-escalation BPV-1
VLP vaccine trial in
horses
R. Kirnbauer, S. Brandt,
S. Shafti-Keramat,
E. K. Hainisch
57. The orphan adapter
protein SLY1 as a novel
anti-apoptotic protein required for thymocyte development
B. Reis, D. Finkenstaedt,
D. K. Finlay,
D. A. Cantrell, K. Pfeffer,
S. Beer
65. Regulation of NK cell
activity through extracellular HLA-B-Associated
Transcript 3
E. Pogge von Strandmann, V. Simhadri,
K. S. Reiners,
H. P. Hansen, A. Engert
73. Analysis of potential
antiviral MX activity in
the chicken
B. Schusser, N. Penski,
A. Reuter, G. Kochs,
P. Staeheli, B. Kaspers,
S. Kothlow
42. In vivo generated
Th17 cells have a stable
memory for IL-17 expression
M. H. Lexberg,
I. Albrecht, A. Förster,
A. Richter, A. Radbruch,
H. D. Chang
50. Characterisation of
effects on growth of
Staphylococcus aureus
mediated by specific
IgGs
B. Tosetti, E. Glowalla,
M. Krönke, O. Krut
58. Micropatterning of
CD4 in the live cell
plasma membrane reveals novel binding
mechanisms to Lck
M. Schwarzenbacher,
M. Kaltenbrunner,
M. Brameshuber,
C. Hesch, W. Paster,
J. Weghuber, B. Heise,
A. Sonnleitner, H. Stokkinger, G. J. Schütz
66. Natural killer cell’s
activation by Immunomodulin for treatment strategy of
recurrent genital herpes
V. Garib, U. Djabborov,
Y. Rasul-Zade
74. MHC typing in swine:
SLA class I and class IIallele distribution in Austrian Large White,
Landrace, and Pietrain
breeding stocks
S. E. Hammer,
J. Deutsch,
B. C. Rütgen, S. Groiß,
W. Gerner,
S. Müller, A. Saalmüller
43. Role of HDAC in T
helper cell development
R. Glauben,
E. Sonnenberg, I. Fedke,
P. Mascagni, M. Zeitz,
B. Siegmund
51. Analysis of the
mechanisms mediating
dendritic cell-based vaccination against Leishmania major
J. K. Schnitzer,
C. Hambrecht,
M. Fajardo-Moser,
K. A. Remer,
H. Moll
59. Stat3 serine 727
phosphorylation upon
activated TLR binding
promotes via
MyD88/TRIF safekeeping of IL-1beta
S. Dreher, F. Schmitz,
R. Ferstl, S. Spiller,
J. Marges, A. Heit, I. Förster, R. Lang, H. Wagner,
C. J. Kirschning
67. Decision making in
NK cells
D. Urlaub, S. Mesecke,
H. Busch, R. Eils,
C. Watzl
75. Porcine coccidiosis adaptive immune response mechanisms
against Isospora suis
H. L. Worliczek,
W. Gerner, A. Saalmüller,
A. Joachim
44. Human
CD4+CD25+Foxp3+ regulatory T cells efficiently
inhibit GvHD induction in
a humanized mouse
model
C. Becker, J. Kubach,
C. Taube, C. Becker,
K. Michel, K. Reifenberg,
H. Jonuleit
52. Virus-like particles: A
cell-free antigen-presenting platform modulating lymphocyte
activation in vitro and in
vivo
H. J. Kueng, V. M. Leb,
D. Haiderer, G. Raposo,
C. Thery, S. V. Derdak,
K. G. Schmetterer,
A. Neunkirchner,
C. Sillaber, B. Seed,
W. F. Pickl
60. Carma1/Bcl10/Malt1
Complexes Transmit
ITAM-coupled NK Cell
Receptor Signals for NFB and MAPK Activation
O. Groß, C. Grupp,
C. Steinberg,
S. Zimmermann,
D. Strasser,
N. Hannesschläger,
W. Reindl, C. Peschel,
A. Krug, J. Ruland
68. Natural killer cells are
modulated in patients
with neuroimmunologic
disorders in response to
treatment with intravenous immunoglobulin
C. Jacobi, M. Claus,
B. Wildemann,
J. Römisch, C. Watzl,
S. Meuer, T. Giese
76. Potential diagnostic
markers for subclinical
endometritis in cows:
TNF-alpha, IL-1 alpha,
IL-1 beta, and IL-8
C. Gabler, M. Drillich,
C. Fischer, C. Holder,
W. Heuwieser,
R. Einspanier
45. Mathematical modeling of the diversity of the
immunological synapse
M. T. Figge,
M. Meyer-Hermann
53. Priming and boosting
of melanA-specific T
cells - in vitro studies on
the importance of antigen-presentation density
J. Dörrie, N. Schaft,
V. Wellner, C. Wohn,
T. Schunder, I. Müller,
E. Kämpgen, G. Schuler
61. Functional analysis
of the riboflavin kinase
and its role in TNF-induced signalling
B. Yazdanpanah,
C. Pongratz,
K. Wiegmann,
H. Kashkar, M. Krönke
69. Myeloid-Derived
“Suppressor” Cells express Rae-1 and activate
NK cells
A. Cerwenka,
E. Schlecker, I. Galani,
N. Nausch
77. Toll-like receptor expression and bacterial
strain dependent
chemokine response in a
primary bovine colonic
epithelial cell culture
model
P. S. Bridger, M. Mohr,
J. Fröhlich, H. Metcalfe,
D. Werling, G. Baljer,
C. Menge
Scientific Programme – Thursday, September 4, 2008 (continued) 13
Time
15.30
16.30
Lecture Hall 1
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
46. The role of the zinc
finger protein MAZR in
CD4/CD8 cell fate decisions during thymocyte
development
S. Sakaguchi, I. Bilic,
M. Hombauer,
A. Schebesta,
W. Ellmeier
54. Propagation-deficient LCMV-derived vaccine vector efficiently
targets dendritic cells to
induce potent T and B
cell responses against
immunogens of choice
L. Flatz, A. N. Hegazy,
A. Verschoor,
A. Bergthaler,
M. Löhning,
D. D. Pinschewer
62. The DEAD-box helicase DDX3X is a critical
component of the TANKbinding kinase 1-dependent innate immune
response
D. Soulat,
T. Buerckstuemmer,
S. Westermayer,
A. Goncalves, A. Bauch,
A. Stefanovic,
O. Hantschel,
K. L. Bennett, T. Decker,
G. Superti-Furga
70. Characterization of a
novel, RORgt-expressing
mucosal NK cell population
S. L. Sanos, A. Mortha,
V. Bui, K. Oberle,
A. Diefenbach
78. Analysis of CD28 in
horses and application
of a polyclonal Ab to induce co-stimulation
S. Ibrahim,
E. Abd El-Gawad,
F. Steinbach
47. 2D-DIGE analysis of
enriched secretory lysosomes of human T and
NK cells
H. Schmidt, C. Gelhaus,
M. Lettau,
M. Nebendahl,
M. Leippe, O. Janssen
55. Vaccination with
MHC class II-heterologous dendritic cells induces protective
immunity against Leishmania major
K. A. Remer, H. Moll
63. Post-transcriptional
regulation of FasL expression: Molecular insights into storage,
activation-induced mobilization and shedding
of a prototypic death
factor
M. Lettau, O. Janssen
71. Specificity of interaction between killer cell
immunoglobulin-like receptors (KIR) and MHC
class I molecules of the
rhesus macaque
(Macaca mulatta)
P. Kruse, C. Rosner,
M. Hermes, L. Walter
79. Species-specific
generation of immune
regulatory molecules by
host pathogen coevolution
R. Kammerer, T. Popp,
S. Haertle, B. B. Singer,
E. Travanty, Z. Qian,
K. V. Holmes,
W. Zimmermann
Lecture Hall 5
Time
Lecture Hall 1
16.45
18.00
Vaccination
Chair: M. Müller, H.J. Schild
In Vivo Imaging
Chair: C. Scheinecker, C. Berek
Immunomodulation
Chair: W. Ellmeier, E. Schmitt
Delineation of plasmablast characteristics
generated in steady-state and in systemic
immune responses
H. Mei
The In Situ Dynamics of Innate and Adaptive Immune Cell Behaviour Revealed By
Intravital Multiphotometry Microscopy
R. Germain
Probing Dendritic cell In vivo Functions
S. Jung
Towards a coronavirus- based multigene
vaccine platform
B. Ludewig
In vivo imaging of Germinal Center B Cells Tec kinases in T cell activation and
A.E. Hauser
function
L. Berg
Modulating Vaccine Responses with
Innate Immunity
B. Pulendran
Non-invasive imaging of inflammation the quest for specificity
A. Wunder
19.00
Lecture Hall 2
14
Lecture Hall 3
Inducible Foxp3-dependent or -independent human CD4+ regulatory T Cells.
R. Bacchetta
Welcome Reception at the Vienna City Hall
NUDIST COLONIES.
CD-1-nude • NMRI-nude • BALB/c-nude
We’ve improved the availability of our nude mouse strains.
For more information, please contact us at:
Call: +49 (0) 9761/ 406-0 • +31 (0) 43 40 77 310
E-mail: [email protected] • [email protected]
[email protected]
Scientific Programme – Friday, September 5, 2008
Time
08.15
09.30
09.30
10.30
Lecture Hall 1
Lecture Hall 2
15
Lecture Hall 3
Chair: M. Säemann, W. Solbach
Mucosal Inflammation
Chair: B. Bohle, D. Männel
Transplantation
Chair: T. Wekerle, R. Schmidt
Innate resistance, inflammation, and
cancer
G. Trinchieri
Role of epithelial barrier function in allergy
P. Brandtzaeg
Antibody-mediated transplant rejection
G. Böhmig
Interferon regulatory factors and innate
immunity in early life
M. Goldman
A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation
S. Meuer
Immune monitoring and therapy in transplantation - from bench-to -bedside
H.D. Volk
The mammalian target of rapamycin and
innate immunity
T. Weichhart
Tumor Necrosis Factor and the consequences of its ablation in vivo
S. Nedospasov
Tolerance through mixed chimerism: how
close to clinical application is it?
T. Wekerle
Time
10.30
12.15
Lecture Hall 1
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
16
Lecture Hall 5
Allergy I
Chair: H. Renz,
F. Horak
Regulatory Lymphocytes I
Chair: L. Klein,
T. Wekerle
Chair: B. Arnold,
H. Ankersmit
Pattern Recognition
Receptors & Myeloid
Cells
Chair: S. Bauer,
C. Bogdan
Innate Immunity:
Regulation
Chair: M. Zeyda,
K. Pfeffer
80. Tracing antigen signatures in the human
IgE repertoire
K. Marth,
M. Novatchkova,
M. Focke-Tejkl,
S. Jenisch, S. Jäger,
D. Kabelitz, R. Valenta
88. Analyses of a novel
regulatory T cell subset
in patients with Systemic
Lupus Erythematosus
(SLE)
M. Bonelli,
A. Savitskaya, E. Feierl,
S. S. Smolen,
C. Scheinecker
96. Role of IL-2 in induction of CD8 T cell tolerance by LSEC
A. K. Schurich, M. Berg,
A. Limmer, H. J. Schild,
L. Diehl, P. A. Knolle
104. Influence of viral infection on recognition of
self RNA
T. von Thülen, M. Nain,
S. Bauer
112. Suppression of
adaptive immune responses by Toll-like receptor ligands
B. Schumak, M. Brock,
F. Jüngerkes,
G. Hartmann, T. Tüting,
P. Knolle, R. Zawatzky,
S. Bauer, A. Limmer
81. Stable dust challenge inhibits allergic airway reactivity through
TLRs 2, 3, 4, 7, 9 and/or
other PRRs/TLRs
R. Ferstl, S. Spiller,
S. Dreher, H. Garn,
H. Fehrenbach,
E. Von Mutius, H. Renz,
H. Wagner,
C. J. Kirschning
89. CD4+ CD25high regulatory T cells suppress T
helper 1 but not T helper
2 cytokines
T. Bollinger,
A. Bollinger, W. Solbach
97. Proliferation of CD8positive T cells in the Lumina of Rat Renal
Allograft Blood Vessels
V. Grau, G. Fuchs-Moll,
W. Padberg
105. TLR7-dependent
recognition of transfer
RNA
Y. Zhao, A. Kaufmann,
K. Steinbach, S. Bauer
113. The cytoplasmic tail
of CD45 is released from
activated phagocytes
and can act as an inhibitory messenger for
T cells
S. Kirchberger,
O. Majdic, S. Blüml,
C. Schrauf, J. Leitner,
C. Gerner, W. Paster,
N. Gundacker, M. Sibilia,
J. Stöckl
82. Composition of B
cell receptor classic antigen-binding site regulates allergic airway
inflammation in a murine
model of experimental
asthma
S. Kerzel, J. Wagner,
T. Rogosch, A. Yildirim,
H. Fehrenbach, H. Garn,
R. F. Maier,
H. W. Schroeder Jr.,
M. Zemlin
90. Induction of CD25Foxp3- regulatory T cells
by chronic antigen stimulation in vivo
W. Hansen,
A. M. Westendorf,
J. Buer
98. Dickkopf 3, a novel
modulator of T cell responses
M. Papatriantafyllou,
G. Moldenhauer,
H. J. Gröne, C. Niehrs,
G. J. Hämmerling,
T. Oelert, B. Arnold
106. Intrabody mediated
retention of TLR2 and
TLR9 in the ER to inhibit
chronic inflammation
T. Böldicke, S. Dreher,
S. Somplatzki,
L. Grosse-Hovest,
B. Maaß,
W. Lindenmaier,
H. Wagner,
C. Kirschning
114. Molecular mechanisms of Staphylococcus
aureus-induced autophagy
K. Sabel, D. Grumme,
S. A. Leggio,
A. Schnaith, M. Krönke,
O. Krut
83. High expression of
inflammatory cytokines,
chemokines and their receptors in lungs of mice
during allergic asthma
remission underlies the
persistence of chronic
lung inflammation
R. Bankoti,
L. El-Housseiny,
G. Dekan, O. Hoffmann,
G. Stingl, M. M. Epstein
91. Transfer of in vitro
expanded human
CD45RA+CD4+CD25hig
h regulatory T cells inhibits early expansion of
conventional T cells in
immunodeficient Rag2-/c-/- mice
T. J. Boeld, J. Albrecht,
K. Doser, R. Eder, J. Stahl,
E. Typlt, E. Obermann,
R. Andreesen,
P. Hoffmann, M. Edinger
99. Toag-1 enables prediction of CMV mediated
transplant tolerance abrogation
W. Gong, M. Klöpfel,
K. Vogt, S. Haase,
A. Reutzel-Selke,
H. Volk, A. Pascher,
B. Sawitzki
107. Analysis of Toll-like
receptor 7 and Toll-like
receptor 9 chimeric molecules
J. Willemsen, P. Yu,
S. Bauer
115. 12/15-lipoxygenase
is involved in the limitation of inflammation and
tissue damage in murine
arthritis
G. Krönke,
J. Katzenbeisser,
S. Uderhardt, W. Baum,
R. Axmann, J. Zwerina,
G. Schett
84. Antigen -specific immunotherapy inhibited
Th2 via GATA-3 and
Th17 cells in an allergic
asthma model.
N. Zhivkova, R. Karwot,
J. H. Maxeiner,
P. Scholtes, K. Soo,
S. Finotto
92. Long-term vaccination efficiency is independent of regulatory T
cells
G. Gasteiger,
W. Kastenmuller,
L. Stross, D. H. Busch,
T. Sparwasser, I. Drexler
100. Mutated CYLD affects the functional state
of dendritic cells
M. Bros, N. Wiechmann,
V. Besche,
N. Hövelmeyer,
S. Reissig,
S. Grabbe, A. Waisman,
A. B. Reske-Kunz
108. The divergent role
of the mammalian target
of rapamycin (mTOR) in
dendritic cells subtypes
M. Haidinger,
T. Weichhart,
M. Poglitsch, M. Hecking,
M. Zeyda, R. Geyeregger,
J. Werzowa, W. H. Hörl,
M. D. Säemann
116. Promoter methylation status is changed
with altered DEFB1 gene
expression in COPD
E. Andresen,
J. Bullwinkel, C. Lange,
H. Heine
85. Selective depletion
of Foxp3+ cells in
DEREG mice allows
functional analysis of
regulatory T cells during
experimental allergic airway inflammation
A. Hartl, K. Lahl,
H. Hamad, A. Ö. Yildirim,
H. Fehrenbach, R. Teich,
H. Garn, H. Renz,
B. Lambrecht,
T. Sparwasser
93. Retrovirally transduced, antigen-specific
T cells for therapy of
type 1 diabetes
N. Mpofu, N. Saal,
M. Hardtke-Wolenski,
M. P. Manns, E. Jaeckel
101. Enhanced nuclear
export of NFATc1 and
impaired translocation of
NFATc2 is observed in
anergic iTreg generated
by tolerogenic DC
H. S. Adler, R. Orth,
K. Streck, E. Graulich,
K. Steinbrink
109. Mammalian target
of rapamycin (mTOR) orchestrates the defense
program of innate immune cells
F. Schmitz, A. Heit,
S. Dreher, K. Tittel,
J. Mages, T. Haas,
A. Krug, K. Janssen,
C. V. Kirschning,
H. Wagner
117. Macrophage phosphoproteome dynamics
after LPS-stimulation
and its shaping by the
MAPK-Phosphatase
DUSP1: a SILAC-based
approach
G. Weintz, J. Olsen,
J. Mages, M. Mann,
R. Lang
Scientific Programme – Friday, September 5, 2008 (continued)
Time
Lecture Hall 1
Lecture Hall 2
86. Molecular and functional analysis of the
antigen receptor of Bet v
1-specific helper T lymphocytes
A. Neunkirchner,
V. M. Leb,
K. G. Schmetterer,
H. J. Kueng, D. Haiderer,
S. Mutschlechner,
B. Bohle, W. F. Pickl
94. BAC-transgenic mice
for depletion of Foxp3+
regulatory T cells:
Homeostatic expansion
of Tregs
J. Suffner,
K. Hochweller, N. Garbi,
G. Hämmerling
87. Cloning, expression
and mapping of allergenic determinants of
alphaS1-casein, a major
cow’s milk allergen
U. Schulmeister,
H. Hochwallner,
I. Swoboda, M. FockeTejkl, M. Nystrand,
A. Harlin, J. Thalhamer,
S. Scheiblhofer, W. Keller,
B. Niggemann, S. Quirce,
C. Ebner, A. Mari,
G. Pauli, B. Geller,
U. Herz, R. Valenta,
S. Spitzauer
95. Lack of Foxp3 Treglinage marker expression
in mouse epithelial cells
C. T. Mayer, K. Lahl,
C. Loddenkemper,
T. D. Sparwasser
Lecture Hall 3
17
Lecture Hall 4
Lecture Hall 5
102. Allogeneic disparities in the surface molecule immunoglobulin-like
transcript 5 (ILT-5) induce potent antibody responses in stem cell
transplanted patients
K. Pfistershammer,,
A. Lawitschka, J. Leitner,
C. Klauser, R. Weigl,
G. Böhmig, G. F. Fischer,
M. Heemskerk,
O. Majdic, W. F. Pickl,
H. Greinix, P. Steinberger
110. Hsp60 modulates
neutrophil functions
A. Osterloh,
M. Piedavent,
F. Geisinger,
B. Fleischer, N. Brattig,
M. Breloer
118. Prophylactic blockade of TLR4 or therapeutic blockade of both
TLR2 and TLR4 protects
mice from Gram-negative infection and subsequent antibiotic therapy
induced fatal septic
shock
C. J. Kirschning,
G. Elson, R. Ferstl,
S. Dreher, T. Müller,
M. Freudenberg,
B. Daubeuf, H. Wagner,
S. Spiller
103. Dendritic cell-activated, endothelial cellspecific CTL recognizing
a minor histocompatibility antigen rapidly induce
transplant vasculopathy
B. B. Bolinger,
D. Engeler, P. Krebs,
S. Miller, B. Ludewig,
M. Hoffmann, P. Clavien,
Y. Tian
111. Spatial separation
of cross-presentation
and endogenous antigen
presentation
S. Burgdorf, C. Schölz,
A. Kautz, R. Tampé,
C. Kurts
119. Biological characterization of mouse beta
defensin 14 - an orthologue of human beta
defensin 3
J. Röhrl, T. Hehlgans
Time
Lecture Hall 2
12.15
13.45
Satellite Lunch Symposium - Octapharma
Immune modulation with intravenous immunoglobulin: the established and the advances
Chair: S. Meuer
Immunthrombocytopenia as the first model for biological treatment with IVIG in chronic inflammatory and autoimmune diseases
P. Imbach
Intravenous Immunoglobulins: mechanisms of action and options for improvement of therapeutic efficacy
F. Nimmerjahn
Basic research in human immunology creates new therapeutic options
S. Meuer
Discussion and wrap-up
Time
Lecture Hall 1
13.00
13.45
Drittmittelförderung der DFG: Kriterien für eine erfolgreiche Antragstellung
Chair: Y. Samstag
A. Strecker
Time
14.00
15.30
Lecture Hall 1
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
18
Lecture Hall 5
Infection I
Chair: F. Schmitz,
S. Ehlers
Allergy II
Chair: B. Linhart,
G. Stary
Regulatory Lymphocytes II
Chair: A. Rosenkranz,
H. Schulze-Koops
Mucosal Immunity
Chair: R. Förster,
M. Pasparakis
B-Lymphocytes
Chair: V. Sexl,
T. Winkler
120. Restricted B cell receptor diversity converts
acute into chronic viral
infection
A. Bergthaler, L. Flatz,
A. Verschoor,
A. N. Hegazy,
E. Horvath, M. Holdener,
K. Fink, B. Odermatt,
D. D. Pinschewer
128. HLA-classII/peptide-TCR interactions of
the single immunodominant T cell epitope of Art
v 1, the major mugwort
pollen allergen
B. Jahn-Schmid,
B. Maillere, V. Leb,
W. Pickl, G. Gadermaier,
F. Ferreira, B. Bohle
136. Generation of induced CD8+Foxp3+ regulatory T cells in vitro
C. Mayer, K. Lahl,
D. Dittlein, V. Wenzel,
O. Gassner, J. Stephani,
C. Loddenkemper,
T. Sparwasser
144. Role of the transcription factor PU.1 in
human lamina propria
macrophages
F. A. Lasitschka,
A. Heidtmann, T. Giese,
G. Wabnitz,
A. Schrödter, J. Winter,
A. Ulrich, S. C. Meuer,
J. Schröder-Braunstein
152. Swiprosin 1 - positive regulator of BCR induced calcium flux
C. Kroczek, C. Lang,
A. Avramidou,
L. Nitschke, A. Elter,
H. M. Jäck, D. Mielenz
121. Interleukin 18 is essential for protective immunity against M.
tuberculosis.
B. Schneider,
D. Korbel, K. Hagens,
M. Koch,
S. H. Kaufmann,
H. Mittruecker,
U. E. Schaible
129. Proteomic analysis
and mass-spectrometric
identification of differentially regulated proteins
in primary human keratinocytes by allergens
S. Ohnesorge, L. Dietz,
P. Pankert,
M. Schnoelzer,
H. Thierse
137. CD8+CD38+ T-cells:
A competent regulatory
T-cell population
A. Bollinger,
H. Fehrenbach,
T. Bollinger, T. Bollinger,
Z. Orinska,
S. Bulfone-Paus
145. Role of eosinophils
in TGF-beta expression
in human intestine
F. Ulmer, S. C. Bischoff,
A. Lorentz
153. Engagement of
CD83 on B cells augments IgG1 response in
vivo
B. Kretschmer,
K. Lüthje,
S. Schneider,
B. Fleischer, M. Breloer
122. Wnt/Frizzled signaling in infectious diseases: Deciphering the
role of FZD1 in mycobacterial infections
N. Reiling,
T. Endermann, S. Ehlers,
J. Neumann
130. Immunosuppression and allergy in organ
transplant recipients: evidence for insufficient
control of allergen specific responses
T. Eiwegger, S. Gruber,
C. Geiger, E. Dehlink,
T. Frischer, P. Jaksch,
W. Klepetko,
Z. Szépfalusi
138. Tolerogenic potential of lentivirally transduced murine DC
overexpressing antiinflammatory molecules
V. Besche,
N. Wiechmann,
S. Trojandt, S. Grabbe,
A. B. Reske-Kunz,
M. Bros
146. CD4+ Foxp3+ regulatory T cell expansion
induced by antigen-driven interaction with intestinal epithelial cells
independent of local
dendritic cells
A. M. Westendorf,
D. Fleissner, S. Jung,
A. D. Gruber, W. Hansen,
J. Buer
154. The analysis of intravital two-photon imaging of germinal
centres implies a novel
lymphocyte migration
and affinity maturation
model
M. Meyer-Hermann,
M. Figge
123. Cavity formation in
tuberculosis is mediated
by interleukin-4 receptor-alpha-dependent
mechanisms
L. Heitmann,
T. Schreiber, T. Thye,
A. N. McKenzie,
A. Cutler, F. Brombacher,
R. D. Horstmann,
C. G. Meyer, S. Ehlers,
C. Hoelscher
131. Long-term tolerance in IgE-mediated allergy through molecular
hematopoietic
chimerism in a murine
model
U. Baranyi, B. Linhart,
N. Pilat, M. Gattringer,
C. Klaus, E. Schwaiger,
F. Muehlbacher,
J. Iacomini, R. Valenta,
T. Wekerle
139. IL-27 inhibits the
development of regulatory T cells via STAT3
M. Huber, V. Steinwald,
A. Guralnik, A. Brüstle,
P. Kleemann,
C. Rosenplänter,
T. Decker, M. Lohoff
147. Split tolerance after
oral vaccination of mice
with recombinant Escherichia coli Nissle
1917 expressing fimbrial
adhesin K88
K. A. Remer,
M. Bartrow, H. Moll,
T. A. Oelschläger
155. Proapoptotic BH3only proteins Bim and
Puma are essential for
apoptosis of germinal
center-derived memory
B cells and antibodyforming cells
S. Fischer,, D. Tarlinton,
A. Strasser
124. Immunological inhibition of gC1qR/p33, a
receptor for C1q, decreases adherence of
Staphylococcus aureus
to microvascular endothelium
S. Sethi, M. W. Laschke,
J. Roller, L. von Mueller,
E. Peerschke,
B. Ghebrehiwet, I. Bajric,
M. D. Menger,
M. Herrmann
132. Generation of an
IgE knock-in mouse and
its use in systemic anaphylaxis in vivo
P. Yu, W. Lübben,
S. Bauer
140. Development of
“would-be” regulatory T
cells and defective control of Th2-cytokine production in natural scurfy
mutant mice
K. I. Lahl, C. T. Mayer,
J. Huehn, C. Loddenkemper, G. Eberl,
J. Buer, T. Sparwasser
148. The role of IL-23/IL17 in Toxoplasma gondii
induced small intestinal
immunopatology
M. L. Munoz-Roldan,
D. Struck, M. Heimesaat,
C. Hoelscher, U. Mueller,
Y. Iwakura, N. Ghilardi,
O. Liesenfeld
156. Identification of a
chemokine receptor profile characteristic for mediastinal large B-cell
lymphoma
U. E. Höpken,
I. Anagnostopoulos,
M. Broemer,
C. Scheidereit,
K. Joehrens, M. Hübler,
H. Stein, M. Lipp,
B. Dörken, A. Rehm
125. The fibrin-derived
peptide B 15-42 (FX06)
for treatment of capillary
leak
M. Gröger, W. Pasteiner,
G. Ignatyev, U. Matt,
S. Knapp, P. Friedl,
D. Zinkl, K. Zacharowski,
R. Hofer-Warbinek,
P. Petzelbauer,
S. Reingruber
133. Murine plasma and
non-plasma B cells express different IgE repertoires
T. Rogosch, S. Kerzel,
L. Sikula, R. Maier,
M. Zemlin
141. TLR2 ligands act
directly on Treg to abrogate suppression of
CD4+CD25- T cells
H. Oberg, M. Juricke,
S. Ussat, H. Ly,
D. Kabelitz, D. Wesch
149. The mesenteric
lymph node regulates
the amplitude of IgA
secretion in the drained
area: potential role of the
spleen in the immune
response against orally
applied cholera toxin
A. Hahn, N. Thiessen,
R. Pabst, M. Ahrendt,
U. Bode
157. The adapter protein
SLy2 represents a newly
identified regulator of cytoskeletal rearrangements
M. L. von Holleben
Scientific Programme – Friday, September 5, 2008 (continued)
Time
Lecture Hall 1
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
Lecture Hall 5
175. Immunopathological basis of lymphocytic
choriomeningitis virusinduced chorioretinitis
and keratitis
M. Zinkernagel, P. Krebs,
B. Bolinger, S. Miller,
B. Ludewig
134. Induced ablation of
mast cells in adult mice:
Slow recovery of mast
cell populations in the
tissues.
J. Scholten,
A. Gerbaulet, B. Hiller,
W. Muller, T. Krieg,
T. Buch, A. Waisman,
K. Hartmann, A. Roers
142. Influence of
CD4+CD25+ regulatory
T cells on the
transendothelial migration of CD4+CD25- T
cells
T. Bedke, M. Kretz,
K. Mahnke, A. H. Enk
150. The role of CXCR5
in antigen-independent
development and antigen-dependent maturation of nose-associated
lymphoid tissue (NALT)
J. Krege, S. Seth,
S. Hardtke, A. Marques
Davalos-Misslitz,
R. Förster
158. Antigen receptor tail
clue of class-switched
memory B cells
N. Engels, C. Heemann,
L. König, T. Tsubata,
S. Griep, V. Schrader,
J. Wienands
127. CD8 T cell-mediated immune responses
against cross-presenting
liver sinusoidal endothelial cells leads to hepatitis
D. Stabenow,
K. Gärtner, M. Svorcova,
M. Odenthal, H. Dienes,
U. Protzer, P. A. Knolle
135. Timothy grass
pollen major allergen Phl
p 1 - a protease?
K. Röschmann,
P. König, A. J. Ulmer,
A. Petersen
143. Expansion of immune-suppressive
V 9V 2 T cells as a novel
regulatory mechanism of
IL-12 secreting dendritic
cells
M. W. Traxlmayr,
A. M. Dohnal, D. Wesch,
D. Kabelitz, T. Felzmann
151. T cell-specific deletion of gp130 renders
the highly susceptible Interleukin-10 deficient
mouse mutant resistant
to intestinal nematode
infection
N. Fasnacht,
M. C. Greweling,
M. Bollati-Fogolin,,
A. Schippers,, W. Müller,
159. Role of basophils in
immunological memory
responses
A. J. Denzel, U. Maus,
M. Rodriguez Gomez,
M. Niedermeier, Y. Talke,
N. Göbel, M. Mack
15.30
16.30
Time
16.45
18.00
19
Lecture Hall 1
Infection
Chair: S. Knapp, I. Förster
Lecture Hall 2
Adaptive Immunity: Regulation
Chair: H. Stockinger, L. Klein
Lecture Hall 3
Adaptive Immunity: B-Cells
Chair: G. Zlabinger, H-M. Jäck
Origin of CD8+ effector and memory T cell Innate and adaptive IL-17 in the control of
subsets
immune responses
D.H. Busch
B. Stockinger
Transcriptional control of B cell development
M. Busslinger
Mutual host pathogen reactions in tuberculosis
U. Schaible
Memory B cell sub-populations
J.C. Weill
Autoregulatory circuits in inflammatory
T cell responses
A. Scheffold
Innate immune response to pneumococcal Innate Immunity in regulation of antibody
pneumonia
mediated inflammation
S. Knapp
R.E. Schmidt
Time
Lecture Hall 2
18.00
19.30
General Assembly DGfI
Chair: S. Meuer
19.30
Departure with buses to the Viennese “Heuriger” Fuhrgassl-Huber
Plasma cell memory
A. Radbruch
Scientific Programme – Saturday, September 6, 2008
Time
08.45
10.00
Lecture Hall 1
Lecture Hall 2
20
Lecture Hall 3
Autoimmunity
Chair: J. Smolen, H. Schulze-Koops
Inflammation
Chair: J. Stöckl, K. Pfeffer
Allergy
Chair: R. Valenta, J. Kalden
The life history of an autoimmune driver
clone
E. Sercarz
Mechanisms of inflammatory bone
destruction
K. Redlich
Human Th17 cells
S. Romagnani
Immunopathogenesis of rheumatoid arthri- Novel cytokines in inflammatory diseases
tis: induction of arthritogenic autoimmune F. Liew
reactions by proinflammatory stimuli
G. Steiner
New facets in mast cell activation
S. Bulfone-Paus
Modeling multiple sclerosis: autoimmune
T and B cells in the pathogenesis of the
brain inflammatory disease
H. Wekerle
From allergens to vaccines
R. Valenta
10.00
10.30
IL-17 and kynurenines in pathogenic
inflammation
L. Romani
Coffee Break / Exhibition
Your Power for Health
Moderne Antikörper-Analyse
Immunologische Produkte
von Greiner Bio-One
Gleichbleibende und reproduzierbare
Bindung von Proteinen
Geeignet für Transmissions-, Fluoreszenzund Lumineszenzmessungen
Konstante, einheitliche Bindungseigenschaften
Vielfältiges Spektrum an Microplatten
und Streifen-Platten
Kompatibel mit automatisierten Systemen
Greiner Bio-One GmbH | Bad Haller Straße 32 | A-4550 Kremsmünster | Phone: (+43) 75 83 67 91-0 | Fax: (+43) 75 83 63 18 | E-Mail: offi[email protected]
www.gbo.com/preanalytics
Time
10.30
12.15
Lecture Hall 2
Lecture Hall 3
Lecture Hall 4
21
Lecture Hall 5
Autoimmunity II
Chair: R. Schwinzer,
G. Staffler
Infection II
Chair: V. Leksa,
O. Sharif
Complement System
Chair: M. Kirschfink,
M. Wahrmann
Cytokines, Chemokines &
their receptors
Chair: U. Höpken,
M. Sibilia
160. CCR7 is essential for regulatory T cell function in antiGBM glomerulonephritis
K. Hochegger, A. Rosenkranz,
A. Rot
168. Immunemodulation by
Siglec-E during Trypanosoma
cruzi infection
H. Erdmann, P. R. Crocker,
B. Fleischer, T. Jacobs
176. Human factor H-related
protein 4 (CFHR4) recruits Creactive protein to the surface
of necrotic cells
M. Mihlan, M. Hebecker,
M. Huber-Lang, R. Dahse,
P. F. Zipfel, M. Józsi
183. gp130 on
macrophages/neutrophils negatively regulates Th17 development during experimental
tuberculosis
J. Sodenkamp, I. Foerster,
W. Mueller, C. Hoelscher
161. The nuclear receptor
PPARgamma serves as an intrinsic regulator of Th17 cell differentiation
L. Klotz,, I. Dani, S. Burgdorf,
A. Waisman, G. Eberl,
J. Alferink, B. Langhans,
T. Klockgether, P. Knolle
169. A novel Leishmania major
amastigote culture system
U. A. Wenzel, S. Möller,
M. Klinger, S. Liebau, T. Laskay,
G. van Zandbergen
177. Regulation of mouse ficolin-B expression in immune
competent cells
V. L. Runza, J. Kürchner,
D. Weber-Steffens,
D. N. Männel
184. The role of optineurin
(FIP2) in adenovirus E3-14.7Kmediated inhibition of TNFR1
apoptosis
L. Klingseisen, G. Knoll,
W. Schneider-Brachert
162. Spontaneous CD8+ T Cell
Mediated Liver Inflammation in
a Transgenic Mouse Model of
Autoimmune Hepatitis
M. Zierden, E. Kühnen,
M. Odenthal, H. P. Dienes
170. The elimination of
Anaplasma phagocytophilum in
vivo requires CD4+ T cells, but
is independent of Th1 cytokines and a wide spectrum of
effector mechanisms
K. Birkner, Y. Kern, B. Steiner,
C. Bogdan, F. D. von Loewenich
178. Functional analyses indicate pathogenic role of factor
H autoantibodies in atypical
hemolytic uremic syndrome
S. Strobel, P. F. Hoyer,
C. J. Mache, E. Sulyok,
P. F. Zipfel, M. Józsi
185. Overlapping functions of
IL-7 and TSLP in lymphoid development
D. Finke, L. Flueck, A. G. Farr,
A. G. Rolink, S. Chappaz
163. Peripheral T cells are the
therapeutic targets of highdose glucocorticoids in experimental autoimmune
encephalomyelitis
S. Wüst, J. van den Brandt,
J. P. Tuckermann, R. Gold,
H. M. Reichardt, F. Lühder
171. Oxidized phospholipids inhibit phagocytosis via a PKA
dependent mechanism
U. Matt, O. Sharif, T. Furtner,
K. Stich, A. Zivkovic, S. Knapp
179. A dual role of the C5a receptor (C5aR) in acute and
chronic dextran sulphate induced models of inflammatory
bowel disease
K. Johswich, M. Martin,
A. Bleich, M. Kracht,
O. Dittrich-Breiholz, E. Gessner,
S. Suerbaum, C. Rheinheimer,
A. Klos
186. Organ-specific suppression of CCL17 production
through InterferonT. Globisch, S. Stutte,
V. Lukacs-Kornek, C. Kurts,
I. Förster
164. The proteasome inhibitor
bortezomib depletes plasma
cells and protects lupus mice
from nephritis
K. Neubert, S. Meister,
K. Moser, F. Weisel, D. Maseda,
K. Amann, T. H. Winkler,
J. R. Kalden, R. E. Voll
172. Control of Persistent HBV
Infection by Hepatitis B Core
Antigen-activated NK cells:
A Possible Mechanism for the
HBV Persistence
L. Huang, P. Chen, P. Knolle
180. Candida albicans CaHGT1
and its role in complement inhibition and modulation of other
virulence factors
I. Lesiak, G. Vogl,
T. Schwarzmüller, M. P. Dierich,
K. Kuchler, R. Würzner
187. Down-regulation of IFNduring HPV-induced carcinogenesis
B. Rincon-Orozco, F. Rösl
165. CD8 T cells specific for a
glomerular antigen induce renal
inflammation in a CD4 help dependent fashion and may
cause progressing Glomerulonephritis
F. Heymann, E. E. HamiltonWilliams, I. Ludwig-Portugall,
S. Quaggin, J. Flöge, H. Gröne,
C. Kurts
173. Acute infection with a single hepatitis C virus strain in
dialysis patients: analysis of
adaptive immune response and
its impact on viral sequence
evolution
L. Weseslindtner,
C. Neumann-Haefelin, S. Viazov,
A. Haberstroh, J. Kletzmayr,
J. H. Aberle, J. Timm,
S. R. Ross, R. Klauser-Braun,
T. F. Baumert, M. Roggendorf,
R. Thimme, H. Holzmann
P419. Characterization of factor
H binding to neutrophil granulocytes
J. Losse, P.F. Zipfel, M. Józsi
188. An IFN reporter mouse
model for the visualization of
the initiation of the Type I interferon response in vivo
P. Dresing, S. Scheu,
R. M. Locksley
166. A new model for inflammatory bowel disease: A transgenic mouse expressing a
crossreactive T cell receptor
recognizing murine and bacterial HSP60
N. Schmidt, T. Joeris,
U. Steinhoff
174. Type I Interferons as virulence-determining factors in
Listeria monocytogenes infections
B. Reutterer, S. Stockinger,
A. Pilz, D. Soulat, R. Kastner,
S. Westermayer, T. Rülicke,
M. Müller, T. Decker
182. Rituximab-induced ADCC
of tumour cells is variably
modified by complement iC3b
A. Dörr, C. Watzl,
M. Kirschfink
189. Chemokine receptor CCR7
contributes to a rapid and efficient clearance of lytic MHV-68
from the lung while bronchusassociated lymphoid tissue harbors virus during latency
J. R. Kocks, H. Adler,
H. Danzer, K. Hoffmann,
D. Jonigk, U. Lehmann,
R. Förster
167. NAADP/Ca2+ signaling: a
new therapeutic target for T cell
mediated autoimmune disease
F. Odoardi, C. Cordiglieri,
W. Dammermann, B. Zhang,
M. Hohenegger, B. V. Potter,
A. Guse, A. Flügel
126. Yersinia enterocolitica differently affects DC subpopulations in vivo
S. E. Autenrieth, T. Linzer,
P. Warnke, S. Schmitz,
I. B. Autenrieth
190. IL-27 acts as a Priming
Signal on Human Keratinocytes
and Antigen- Presenting Cells
J. Zeitvogel, T. Werfel,
M. Wittmann
Immunity for Life
Immunology for Health
September 13 – 16, 2009
Berlin, Germany
2nd European Congress
of Immunology
www.eci-berlin2009.com
Venue
Congress President
Congress Secretariat
International Congress Center Berlin (ICC Berlin)
Prof. Dr. med. Reinhold E. Schmidt
K.I.T. GmbH Association & Conference
Neue Kantstraße / Ecke Messedamm
Medizinische Hochschule Hannover
Management Group & Co. KG
14057 Berlin, Germany
Klinik für Immunologie und Rheumatologie
Kurfürstendamm 71
www.icc-berlin.de
Carl-Neuberg-Straße 1
10709 Berlin, Germany
30625 Hannover, Germany
Phone: +49 (0)30 – 246 03-0
Under the auspices of EFIS
Phone: +49 (0)511– 532-6656
Fax: +49 (0)30 – 246 03-200
Fax: +49 (0)511– 532-9067
E-Mail: [email protected]
E-Mail: [email protected]
www.kit-group.org
Time
Lecture Hall 1
10.30
12.45
Satellite Lunch Symposium - Phadia
Vom rekombinanten Allergen zu neuen Allergietherapien
Chair: R. Valenta, N. Reider
Rekombinante Allergene: Vom Beginn zur Gegenwart
H. Breiteneder
Rekombinante Nahrungsmittelallergene
K. Hoffmann-Sommergruber
Klinische Anwendungen für rekombinante Allergene
P. Schmid-Grendelmeier
Klinische Erfahrungen mit Allergenchips
J. M. Baron
Die Komplexitaet von zellulären Allergietesten
J. Kleine-Tebbe
Immuntherapie und Verlaufkontrolle mit rekombinanten Allergenen
G. Pauli
12.45
13.00
Pause (mit Snack)
Time
Lecture Hall 1
13.00
13.45
Klinische Fälle aus der Allergologie: Wie hätten Sie entschieden?
Chair: Z. Szepfalusi, G. Pauli
Werner Aberer, Reinhart Jarisch, Felix Wantke und Stefan Wöhrl präsentieren klinische Fälle aus der Allergologie
14.00
14.30
Best Poster Awards
Chair: J. Smolen, S. Meuer
Time
Lecture Hall 2
15.00
General Assembly ÖGAI
Chair: J. Smolen, M. Säemann
23
Warum soll ich in die Ferne schweifen,
wenn mir ein Diagnostikunternehmen
alles bietet, was ich brauche?
Siemens Healthcare Diagnostics. Das Engagement, um Ihren
individuellen Bedürfnissen auf den Grund zu gehen.
Oberste Priorität hat für Sie eine optimale Patientenbetreuung, und für uns, Ihnen dabei zu helfen, dieses
Ziel zu erreichen. Dazu bietet Ihnen Siemens ein beachtliches Portfolio leistungsorientierter Systeme, ein
umfangreiches Testmenü sowie innovative IT- und Servicelösungen an. Sprechen Sie mit unserem
Expertenteam über Ihre Vorstellungen – gemeinsam finden wir die optimale Lösung für Sie. Treten Sie
näher: www.siemens.com/customer-first
Answers for life.
A91DX-0701169-A1-0000
© 2008 Siemens Healthcare Diagnostics Inc. All rights reserved.
Poster Viewing
25
09.30 – 10.30 hrs
09.30 – 10.30 hrs
T-Lymphocytes I
Chair: B. Jahn-Schmid, C. Scheinecker
P001 – P028
Chair: G. Böhmig, M. Säemann
P209 - P233
T-Lymphocytes II
Chair: W. Pickl, H. Stockinger
P029 – P056
Allergy
Chair: B. Bohle, S. Bulfone-Paus
P234 - P264
Chair: T. Weichhart, M. Gilliet
P057 - P075
Infection
Chair: U. Schaible, S. Knapp
P265 - P296
Signal Transduction
Chair: L.J. Berg, W. Ellmeier
P076 - P094
Mucosal Immunity
Chair: S. Meuer, P. Brandtzaeg
P297 - P308
Tumor Immunology
Chair: O.J. Finn, T. Blankenstein
P095 - P117
15.30 – 16.30 hrs
15.30 – 16.30 hrs
Autoimmunity I
Chair: R. Germain, E. Sercarz
P309 - P329
Chair: M. Zeyda, S. Beissert
P118 - P134
Autoimmunity II
Chair: G. Steiner, J. Kalden
P330 - P352
Pattern Recognition Receptors & Myeloid Cells
Chair: F. Schmitz, J. Stöckl
P135 - P151
Complement System and B-Lymphocytes
Chair: F. Melchers, A. Radbruch
P420 and P353 - P360
NK Cells
Chair: C. Watzl, V. Sexl
P152 - P164
Regulatory Lymphocytes
Chair: L. Klein, R. Bacchetta
P361 - P383
Chair: H. Lassmann, T. Weichhart
P165 - P187
Cytokines, Chemokines & their receptors
Chair: F.Y. Liew, L. Romani
P384 - P404
Immunomodulation
Chair: M. Fischer, G. Zlabinger
P188 - P208
Chair: B. Kaspers, A. Saalmüller
P405 - P418
Business Meetings
26
As per date of printing
Closed Business Meetings
10.00 – 12.00 hrs
Steering Committee Meeting ECI 2009
12.00 – 14.30 hrs
Vorstandssitzung DGfI
Lecture Room 25 / Level 8
Hotel Regina – Salon Makart
11.00 – 13.00 hrs
Promotion Committee Meeting des ECI 2009
12.30 – 14.00 hrs
Sitzung der DGfI Kommission “Fachimmunologe”
12.00 – 14.00 hrs
Arbeitskreise der DGfI
09.00 – 11.00 hrs
DGfI Educational Committee
Satellite Lunch Symposia
Thursday, September 4, 2008, 12.15 – 13.45 hrs, Lecture Hall 1
B cell: Promising target in autoimmune diseases
Chair: J. Smolen
The biology of the B cell in autoimmune diseases
A. Radbruch
Clinical experiences with B cell therapies
T. Dörner
Safety: Experiences with Rituximab
H-P. Brezinsek
Friday, September 5, 2008, 12.15 – 13.45 hrs, Lecture Hall 2
Immune modulation with intravenous immunoglobulin: the
established and the advances
Chair: S. Meuer
Introduction
S. Meuer
Immunthrombocytopenia as the first model for biological treatment with IVIG in chronic inflammatory and
autoimmune diseases
P. Imbach
Intravenous Immunoglobulins: mechanisms of action and options for improvement of therapeutic efficacy
F. Nimmerjahn
Basic research in human immunology creates new therapeutic options
S. Meuer
Discussion and wrap-up
Saturday, September 6, 2008, 10.30 – 12.45 hrs, Lecture Hall 1
Vom rekombinanten Allergen zu neuen Allergietherapien
Chairs: R. Valenta, N. Reider
Rekombinante Allergene: Vom Beginn zur Gegenwart
H. Breiteneder
Rekombinante Nahrungsmittelallergene
K. Hoffmann-Sommergruber
Klinische Anwendungen für rekombinante Allergene
P. Schmid-Grendelmeier
Klinische Erfahrungen mit Allergenchips
J.M. Baron
Die Komplexitaet von zellulaeren Allergietesten
J. Kleine-Tebbe
Immuntherapie und Verlaufkontrolle mit rekombinanten Allergenen
G. Pauli
12.45 - 13.00 Pause (mit Snack)
13.00 - 13.45 Klinische Fälle aus der Allergologie: „Wie hätten Sie entschieden”
27
Information on Posters
28
Poster Topics
P01 T-Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P02 Innate Immunity: Antigen-Presenting Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P03 Signal Transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P04 Tumor Immunology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P05 Innate Immunity: Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P06 Pattern Recognition Receptors & Myeloid Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P07 NK cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P08 Vaccines & Adjuvants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P09 Immunomodulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P10 Alloimmunity & Tolerance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P11 Allergy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P12 Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P13 Mucosal Immunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P14 Autoimmunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P15 B-Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P16 Regulatory Lymphocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P17 Cytokines, Chemokines & their receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P18 Veterinary Immunology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P19 Complement system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
P001 – P056
P057 – P075
P076 – P094
P095 – P117
P118 – P134
P135 – P151
P152 – P164
P165 – P187
P188 – P208
P209 – P233
P234 – P264
P265 – P296
P297 – P308
P309 – P352
P353 – P360
P361 – P383
P384 – P404
P405 – P418
P420 – P420
•
Posters will be on display from Wednesday, September 3, (15.00 hrs) to Saturday, September 6, 2008,
(15.00 hrs).
•
Poster mounting will be possible on: Wednesday, September 3, 2008 from 10:00 - 15:00.
•
Removal will be possible on: Saturday, September 6, 2008 from 14:30 - 15:30.
Please note that posters not removed by then, will be taken down by conference staff and will not be
stored or forwarded to the authors after the meeting.
•
You will find your poster board number in the author index at the end of the abstract book.
Presence at Posters
In order to enable discussion and interaction with other participants, we request you or another member of your
group to be at your poster board at the following times:
•
Thursday, September 4, 2008, 09.30 – 10.30 hrs
T-Lymphocytes-1
P001 - P028
T-Lymphocytes-2
P029 - P056
P057 - P075
Signal Transduction
P076 - P094
Tumor Immunology
P095 - P117
•
•
•
Thursday, September 4, 2008, 15.30 – 16.30 hrs
Pattern Recognition Receptors & Myeloid Cells
NK Cells
Immunomodulation
P118 - P134
P135 - P151
P152 - P164
P165 - P187
P188 - P208
Friday, September 5, 2008, 09.30 – 10.30 hrs
Allergy
Infection
Mucosal Immunity
P209 - P233
P234 - P264
P265 - P296
P297 - P308
Friday, September 5, 2008 15.30 – 16.30 hrs
Autoimmunity-1
Autoimmunity-2
B-Lymphocytes
Regulatory Lymphocytes
Cytokines, Chemokines & their receptors
Complement System
P309 - P329
P330 - P352
P353 - P360
P361 - P383
P384 - P404
P405 - P418
P420
If this is not possible, please leave a note on your poster board detailing the times when you will be present at the board.
Information for Speakers
29
Projection and Technical Setting
•
All rooms will be equipped with data- and overhead projection (no slides).
•
It is essential that you load and view your presentation in the slide preview room preferably in the
morning of the day your talk is scheduled, but no later than 2 hours in advance.
•
The lecture rooms are exclusively equipped with Windows-PCs (no Macintosh machines). In case you
absolutely need to use your own laptop or notebook, please contact the preview center well in advance
of your talk.
•
Please bring a USB-stick or CD-ROM, all formatted for Windows® (PC). You may want to carry a second
disk/CD as a back-up in case there is any unsolvable technical problem.
•
File Format: Microsoft® Power Point™ presentation formatted for Windows® (PC) only. (Operating
system: Windows XP®)
•
Preferred Resolution: XGA (1024 x 768 pixel)
Preview Room
The Speaker’s Preview will be located in Room Nr. 11 on Level 7. Equipment for a final check of the sequence of your
presentation is available in the preview room. All presenters should bring their electronic presentation to the preview
room preferably in the morning of the day of the talk, but no later than 2 hours before the start of the session. For
sessions starting at 08.15 hrs, the PowerPoint presentations should be handed in the previous day.
Opening hours of the preview room:
Wednesday, September 3, 2008 12.00 – 18.00
07.30 – 18.00
07.30 – 18.00
08.15 – 15.00
Programme Changes
The organisers cannot assume any liability for changes in the programme due to external or unforeseen
circumstances.
30
Abstract Books
You will find an Abstract Book in your conference bag.
Accreditation
The Joint Annual Meeting of Immunology has applied for credits at the European Accreditation Council for Continuing Medical Education, Institution of the UEMS.
The number of credits (which will be announced after the meeting) will figure on the respective confirmation,
which will also be sent after the meeting.
The rules of the EACCME state that participants are kindly asked to fill in the feedback (evaluation) form included
in the conference bag. It can be returned to the registration desk.
Participants applying for EACCME Credits will have to have their badge scanned daily at the registration
desk before entering the conference. The confirmation will be mailed after the conference at the end of
September.
Die österreichische Akademie der Ärzte hat an diese Veranstaltung 41 Diplomfortbildungspunkte
vergeben.
Admission to Lecture Halls
Participants are requested to enter the lecture halls via Level 8 only.
Badges
Participants will receive their name badges from the conference registration desk. Since only registered participants will be permitted to attend scientific sessions, the exhibition and poster areas, you are kindly asked to wear your badge when entering the
congress venue. Please note that admission to scientific sessions is strictly restricted to participants wearing their badges. Exhibitors and accompanying persons are not entitled to attend the scientific sessions. Lost badges can be replaced at the registration desk. However, a handling fee of € 20,- will be charged.
The following badge-colours are used at the Congress:
White
Yellow
Green
Red
Participants
Accompanying Persons
Exhibitors
Staff
Cancellations and Refunds
Notice of cancellation must be made in writing by registered letter or fax to the Congress Office.
The policy for refunding registration fees is as follows:
Written cancellation received:
- before July 31, 2008: 75% refund
- after July 31, 2008: no refund
The date of the postmark or fax ID is the basis for considering refunds. Refunds will be made after the congress.
Cash Bar
Snacks and drinks may be purchased at the cash bar on Level 8 during congress hours.
Certificate of Attendance
Confirmations of attendance will be issued at the registration desk.
City Tour
The city tour “Classical Vienna – A City Stroll” will take place on Thursday, September 4, 2008. It is free of charge for accompanying persons, however, registration in advance is mandatory.
Coffee Breaks
During the session breaks, refreshments will be served free of charge to participants wearing name badges.
Exhibition Opening Hours
15.00 – 17.00 hrs
08.15 – 17.00 hrs
08.15 – 17.00 hrs
08.45 – 15.00 hrs
Hotel and Tours Desk
Mondial, the official travel agency of the meeting, will be present at the conference on
Wednesday, September 3, 2008 from 14.30 – 17.30 hrs and on
Thursday, September 4, 2008 from 07.30 – 09.30 hrs.
If you have any questions regarding your hotel booking or the city tour, please approach Mondial. They will be located near the
registration desk.
Internet
A few internet stations will be available at the conference. Please ask at the registration desk. You may also find small internet
cafés throughout the city.
31
Message Board
A Message Board and notice of the daily programme are available on Level 7 and Level 8.
Poster Mounting and Removal
There are four poster sessions: Thursday and Friday from 09.30 – 10.30 hrs and from 15.30 – 16.30 hrs. Poster mounting will be
possible on Wednesday, September 3, 2008 from 10.00 – 15.00 hrs. Poster removal will be possible on Saturday, September 6,
2008 from 14.30 – 15.30 hrs. Please note that the organisers cannot assume any liability for loss or damage of posters displayed
in the poster area. Posters that are not removed by 15.30 hrs on Saturday, September 6, 2008 will be removed by staff and will
not be stored or forwarded to the author after the meeting.
Preview Room
The Speaker’s Preview will be located in Room Nr. 11 on Level 7. Equipment for a final check of the sequence of your presentation is available in the preview room. All presenters should bring their electronic presentation to the preview room preferably in
the morning of the day of the talk, but not later than 2 hours before the start of the session. For sessions starting at 08.15 hrs,
the PowerPoint presentations should be handed in the previous day.
Following are the opening hours of the preview room:
12.00 – 18.00
07.30 – 18.00
07.30 – 18.00
08.15 – 15.00
Public Transport
Registered congress participants receive a 4-days-ticket when picking up their registration materials. This ticket is valid for all public transport within Vienna from Wednesday, September 3, 2008 to Saturday, September 6, 2008. This ticket is not valid for going
to the airport, since the airport is out of town. Congress participants are kindly requested to return their ticket if it is not needed.
Registration Desk opening hours
10.00 – 18.00
07.30 – 18.00
07.30 – 18.00
08.15 – 15.00
Smoking Policy
The Joint Annual Meeting of Immunology is a “No-smoking-Conference”. Please note that smoking is banned from all public
buildings. Restaurants and bars may, depending on size, be declared either as “smoking” or “no-smoking” locations or have
separate areas and ventilation systems.
Staff
Should you have any questions, congress staff, recognizable by a blue t-shirt and red badge, will be pleased to help you.
Registration Fees
32
Onsite registration
10.00 – 18.00
07.30 – 18.00
07.30 – 18.00
08.15 – 15.00
Payment received
before June 15, 2008
after June 15, 2008 and on-site
Members
EUR 190.—
EUR 300.—
Student Members*
EUR 95.—
EUR 135.—
Non-Members
EUR 280.—
EUR 390.—
Student Non-Members*
EUR 140.—
EUR 180.—
Accompanying Persons
EUR 60.—
EUR 60.—
Day Ticktet Member
EUR 140,—
Day Ticket Non-Member
EUR 180,—
* please provide a copy of an ID together with your registration
What is covered by the registration fee?
Participants
•
•
•
•
•
•
•
Admission to all scientific sessions
Access to the exhibition
Coffee breaks
Welcome reception at the City Hall
Thursday, September 4, 2008, 19.00 hrs
Abstract book
Programme
4-days public transport ticket
Accompanying persons
•
•
•
Admission to the welcome reception at the City Hall
Classical Vienna City Tour*,
Access to the exhibition and coffee breaks
(no admission to lectures)
*Please note that the classical city tour is not available for
on site registrations of accompanying persons.
Payment of registration fees may be made in cash (Euros only), by maestro debit card, or by the following credit cards:
Diners Club, Mastercard, Visa.
Please note that the reduced registration fee is only applicable if it has been credited to the congress account before the deadline. Registering without performing an actual payment is not sufficient to benefit from the reduction. Pre-registration without
payment of the registration fee is possible. The full fee is to be paid at the registration desk.
Cancellations and refunds:
The policy for refunding registration fees is as follows:
Written cancellation received:
- before July 31, 2008: 75% refund
- after July 31, 2008: no refund
The date of the postmark or fax ID is the basis for considering refunds. Refunds will be made after the congress.
General Information
33
Bank services - Money matters
Banks are open from 8.30 – 12:30 and from 13:30 – 15:00, Monday to Friday. Some banks are also open on Thursday afternoons
until 17:30 hrs. Cash machines (ATMs), which accept all major international bank cards, are available throughout the city. There
is a cash machine in the main entrance of the Vienna General Hospital. The currency of Austria is the Euro (€). Major credit cards
are widely accepted, but please always check beforehand.
Car Parking
The Vienna General Hospital has approximately 800 car parking spaces available for visitors in an underground car park. The
entrance is at Währinger Gürtel.
Eating out in Vienna
Vienna has a broad variety of local and international restaurants, many of them located in the old city and in the vicinity of the conference venue.
Emergency services
The phone number to dial for emergencies is 112.
GSM cell phone roaming
GSM cell/mobile phone roaming is available without any problems for all major international providers. It is advisable to inquire
beforehand at your provider which roaming company in Austria offers the cheapest tariffs.
Insurance
In registering for the Joint Annual Meeting of Immunology 2008 participants agree that neither the organising committee nor
the congress office assume any liability whatsoever. Participants are requested to make their own arrangements for health and
travel insurance.
Internet and printing facilities
A few internet stations will be available at the conference. Please ask at the registration desk. You may also find small internet
cafés throughout the city.
Language
The official language of the congress will be English (no simultaneous translation).
Medical care
The Austrian National Health Service may be used by all persons from European Union countries who have the E111 Form (EHICard). This form/card should be obtained at the health service or post office of the visitor’s home country before travelling to
Austria. It is advisable for participants from countries outside the European Union to take out medical insurance before reaching
Austria, since they will be charged for access to the national health system.
Pharmacies
Medicines that do not require a medical prescription may be purchased over the counter. If you need advice, do not hesitate to
ask the pharmacist. If you usually take medication, it is advisable to bring a sufficient amount with you for your trip. Pharmacies
in the vicinity of the conference venue are on Zimmermannplatz 1, 1090 Vienna. There are duty pharmacies open 24 hours a day.
Outside each pharmacy there is a list of the nearest duty pharmacies, or you may ask at your hotel reception for more information.
Safety - Crime
Visitor safety is generally adequate. Like in any other major European city, you can walk everywhere using common sense. Pick
pocketing in heavily visited tourist zones or in public transport lines might be a concern.
Unfortunately experience has shown that some basic precautionary measures should always be kept in mind in any city:
- Do not carry important items like flight tickets, passports etc. with you when visiting the conference or strolling through the city;
leave them in the hotel safe during your stay. Rather carry a photocopy of your passport or an identity card with you.
- Try not to carry all documents, money, credit cards and other essential items and valuables in one bag. If it gets lost or stolen,
everything will be gone and might be difficult to replace on short notice, especially passports and visa to return to your country
of residence.
- Take off your name badge when leaving the conference centre.
Shops
Shops in Vienna are generally open between 09.00 and 18.00 hrs Mon-Fri, and between 09.00 and 12.00 on Saturdays. Some
shops are open until 19.00 Mon-Fri and until 17.00 on Saturdays. Shops are usually closed on Sundays, except for a few establishments with special permits.
Taxis
There are Taxi ranks throughout the city, but calling is often your best option. Please address your hotel reception or the registration desk of the conference venue. A taxi station can be found in front of the main entrance at Level 5 and at Lazarettgasse
(exit on Level 4).
Tipping
Tips are not obligatory in Austria, although people usually tip approximately 10% at restaurants, cafés and bars. Hotel and airport porters will accept tips, depending on the luggage.
General Information
34
Travelling within Vienna
Registered congress participants receive a 4-days-ticket when picking up their registration materials. This ticket is valid for all public transport within Vienna from Wednesday, September 3, 2008 to Saturday, September 6, 2008. This ticket is not valid for going
to the airport, since it is out of town. Congress participants are kindly requested to return their ticket if it is not needed.
For accompanying persons and exhibitors tickets are available from machines at underground stations (maestro debit cards accepted), at news agents’, or at Vienna Transport Authority’s ticket offices. Tickets bought in advance are cheaper and must be
punched in a blue ticket cancelling machine on the tram or bus, or at the barrier before boarding the underground train.
Single trip tickets can be used for any single trip within Vienna. You may change lines (and switch between bus, tram, underground, or urban train), but you may not interrupt your journey. Ticket price: EUR 1.70 when bought in advance; EUR 2.20 when
bought in the means of transport.
The 24-hour pass is valid throughout Vienna for exactly 24 hours from the time it is punched. Price: EUR 5.70
The 72-hour pass is valid throughout Vienna for exactly 72 hours from the time it is punched. Price: EUR 13.60
The 8-day ticket is valid for any eight days, not necessarily eight consecutive days. It is a rover ticket, which means you can travel
all around Vienna. You can also use the ticket for several people travelling together. Simply punch one strip for each person in the
group. Price: EUR 27.20
Week-pass valid from Monday to Monday, 09.00 hrs. Price: EUR 14.00
A taxi is the most comfortable way of getting around the city but also the most expensive. They are identifiable by their roof-sign
which is lit when available. Prices must be displayed inside the cab and meters (which are compulsory in all cabs) will indicate
the fare.
Travelling from and to the Airport
Vienna International Airport is located 13 kilometres south east of Vienna.
City Airport Train (CAT)
The train service between the airport and the city centre (City Air Terminal – Station ‘Wien Mitte’) is every 30 minutes and takes
16 minutes. It is covered from 6:05 hrs to 00:05 hrs (Airport to City) and from 5:38 hrs to 23:38 hrs (City to Airport). Tickets may
be purchased online (EUR 8.00 single or EUR 15.00 return), from ticket machines at the airport/station (EUR 9.00 single or EUR
16.00 return) or on board (EUR 10.00 single). From ‘Wien Mitte’ you can take the green line (U4) direction Heiligenstadt and get
off at ‘Spittelau’ (five stops) and then take the brown line (U6) direction Siebenhirten and get off at Michelbeuern-Allgemeines
Krankenhaus.
Taxi fares to the conference venue are about EUR 35.00 and take around 25 minutes. There is a taxi rank outside the airport terminal. Night-time fees are slightly higher.
Travelling to the Vienna General Hospital by Public Transportation
The Vienna General Hospital (the congress venue) is easily reachable by taking the subway line U6 (the brown line) and getting
off at Michelbeuern – Allgemeines Krankenhaus. Furthermore, it can be reached by tramway 42, tramways 5 and 33 (stop
Lazarettgasse) as well as tramways 43 and 44 (stop Alser Straße).
Vienna
Vienna, the capital of Austria, 2 million inhabitants, is situated on the banks of the Danube. Vienna is a dream city for anyone with
an interest in history. Narrow, medieval alleyways and grand boulevards lead to historic sights such as the Imperial Palace (Hofburg), Belvedere Palace, Burgtheater, the Spanish Riding School, St. Stephen’s Cathedral, the Opera House, Karlskirche, or
Schönbrunn Palace. Vienna has been synonymous with music for centuries, and was home to Mozart, Beethoven, Schubert and
Johann Strauss. The Vienna Philharmonic Orchestra is one of the world’s top orchestras; the Vienna Boys’ Choir is triumphantly
successful wherever it tours. Vienna possesses a lively and vast array of cultural attractions, from classical or experimental theatre, film or dance festivals, opera or operetta, to exhibitions and concerts. The Museum of Fine Arts is one of the world’s largest
and most distinguished museums, housing priceless works of art. Art accompanies you wherever you go in Vienna - even some
of its underground stations are listed properties on account of their elegant, ornamental Jugendstil (Art Nouveau) style designed
by Otto Wagner. For more information about Vienna, please see www.aboutvienna.org.
Venue
35
Location of the Vienna General Hospital and the Lecture Centre
HÖRSAALZENTRUM
EBENE 07/08
GENERAL INFORMATION
Congress venue
Vienna General Hospital
Allgemeines Krankenhaus Wien
Lecture Hall Centre
Hörsaalzentrum
Währinger Gürtel 18-20
A-1090 Vienna, Austria
Public transportation in Vienna
The Vienna General Hospital (the congress venue) is easily reachable by taking the subway line U6 and getting off
at the station ”Michelbeuern – Allgemeines Krankenhaus”. Furthermore it can be reached with the tramway 42, the
tramway 5 and 33 (station ”Lazarettgasse”) as well as the tramways 43 and 44 (station ”Alser Strasse”)
Venue
36
Level 7
Access from main entrance
No entrance to Lecture Halls.
Please use the doors on Level 8.
Escalators to main entrance
Red Elevators
Green Elevators to main entrance
Lecture
Hall 4
?
?
?
?
?
?
Exhibition
Exhibition
Lecture
Hall 5
Lecture
Hall 3
Lecture
Hall 1
Exhibition
Lecture
Hall 2
?? ??
Coffee
??
Registration
Coffee
Coffee
Cloakroom
Meeting
Room 13
Preview
Room
Level 8
Access to Lecture Halls
Entrance to Lecture Halls
Escalators to main entrance
Green Elevators to main entrance
Red Elevators
?? ??
Posters
?
??
Lecture
Hall 3
Posters
Posters
Lecture
Hall 1
Lecture
Hall 2
??
Lecture
Hall 5
?
?
?
Posters
?
and
?
Exhibition
Posters
?
?
Lecture
Hall 4
Cash Bar
?
Coffee
Posters
Meeting
Room
25
Social Events
37
Welcome Reception by the Mayor of Vienna at the Vienna City Hall
The mayor of the city of Vienna is pleased to invite you to a Welcome Reception. Meet your colleagues at this event. Enjoy the
evening with a Buffet and live music.
Dress code: business attire
Attendance is free for registered participants and accompanying persons. Those who have registered prior to the congress
should have received their ticket with the congress material. Please remember to bring your ticket.
Please note that attendance is limited and advance registration is mandatory in order to receive a ticket!
A limited number of tickets will still be available for onsite bookings.
Venue: Vienna City Hall, Lichtenfelsgasse 2, 1010 Vienna
Directions: From the conference venue take the brown underground line U6 (direction Siebenhirten) one stop and get off at Alser
Strasse. Take the tram 43 (direction Schottentor) and get off at Landesgerichtsstrasse. From there you can walk along Landesgerichtsstrasse until you reach the city hall on your left hand side. Walk past the city hall and turn left into Lichtenfelsgasse. The
entrance to the reception is on your left.
Alternatively you can take the brown underground line U6 (direction ‘Floridsdorf’) three stops and get off at ‘Spittelau’. Take the
green underground line U4 (direction ‘Hütteldorf’) three stops and get off at ‘Schottenring’. Take the purple underground line U2
(direction ‘Karlsplatz’) two stops and get off at ‘Rathaus’. Take the exit towards the front of the train and turn left and cross the
street. This is Lichtenfelsgasse. The entrance to the Reception is on the left hand side.
Friday, September 5, 2008, 19.30 hrs.
Dinner at a Viennese “Heuriger”
An evening spent in typical Austrian wine taverns in Vienna. You will be served a delicious Austrian buffet and excellent local
wines while enjoying the atmosphere of a traditionally decorated restaurant. “Heuriger” could be translated with “of this year”
and means a young crisp wine produced during the current wine season. Only wine producers serving their own product,
grown in the vineyards of Vienna, may call their tavern “Heuriger”.
Dress code: casual
Venue: Weingut Fuhrgassl Huber
Neustift/Walde 68
1190 Vienna
Buses depart from the main entrance on Level 5 of the Vienna General Hospital, at 19.30 hrs and return in the late
evening.
Price per ticket including transport, music, food and beverages: EUR 45.–
Please note that advance registration is mandatory in order to receive a ticket! A limited number of tickets will still be
available for onsite bookings.
Underground Map
38
Congress
venue
Welcome
Reception
9
City Map
39
;TRcdaT2T]caTÛcWT
EXT]]P6T]TaP[7^b_XcP[
"
$
!
&
!
(
#
"
'
%
1) Lecture Centre of the Vienna
General Hospital (AKH)
2) City Hall (Welcome Reception)
3) Arcotel Boltzmann
4) Mercure Josefshof
5) Hotel & Palais Strudlhof
6) Carlton Opera
7) Wandl
8) Atlas
9) Academia
10) Pension Ani Falstaff
11) Pension Ani
12) Regina
13) Royal
Exhibition – General Information
40
Exhibiton Organiser:
Name
Address
MAW – Medizinische Ausstellungs- und Werbegesellschaft
Freyung 6
1010 Vienna, Austria
Telephone
Ms. Ingrid Winkler:
Ms. May-Britt Ernst:
+43 1 535 6016
[email protected]
Fax
E-mail
+43 664 441 8285
+43 664 105 2018
Exhibition Dates & Opening hours:
15.00 – 17.00 hrs
08.15 – 17.00 hrs
08.15 – 17.00 hrs
08.45 – 15.00 hrs
Poster Mounting, Poster Viewing, Poster Removal Hours
Wednesday, September 3, 2008 – poster mounting
Wednesday, September 3, 2008 – poster viewing
Thursday, September 4, 2008 – poster viewing
Friday, September 5, 2008 – poster viewing
Saturday, September 6, 2008 – poster viewing
Saturday, September 6, 2008 – poster removal
10.00 – 15.00 hrs
15.00 – 18.00 hrs
08.15 – 18.00 hrs
08.15 – 18.00 hrs
08.45 – 14.30 hrs
14.30 – 15.30 hrs
Location
Venue
Exhibition Areas
Address
Level 7 and Level 8
Währinger Gürtel 18-20, 1090 Vienna, Austria
List of Sponsors, Exhibitors and Advertisers*
41
Ärztezentrale Adressen- und Drucksortenverlag, Vienna, Austria
Abd Serotec- Endeavour House, Oxon, United Kingdom
Acris Antibodies, Hiddenhausen, Germany
Active Motif Europe, Rixensart, Belgium
Aesca Pharma, Traiskirchen, Austria
Alk Abello Allergie – Service GmbH, Linz, Austria
Allergopharma, Vienna, Austria
AstraZeneca Österreich, Vienna, Austria
Becton Dickinson Austria, Schwechat, Austria
Bencard Allergie, Vienna, Austria
Bender Medsystems, Vienna, Austria
Biomedica, Vienna, Austria
Bio-Rad Laboratories, Munich, Germany
Biotest AG, Dreieich, Germany
Biozym Biotech Trading, Vienna, Austria
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
CellGenix Technologie Transfer, Freiburg, Germany
Cell Kinetice, Lod, Israel
2nd European Congress of Immunology – ECI 2009
eubio, Vienna, Austria
Fermentas, St. Leon-Rot, Germany
GE Healthcare Europe, Vienna, Austria
Greiner Bio – One, Kremsmünster, Austria
Hal Allergy, Vienna, Austria
*(as per printing date)
List of Sponsors, Exhibitors and Advertisers*
42
Invitrogen, Karlsruhe, Germany
Jackson ImmunoResearch Europe Ltd., Suffolk, United Kingdom
LaVision BioTec, Bielefeld, Germany
Mabtech AB, Nacka Strand, Sweden
Ferdinand Menzl Medizintechnik, Vienna, Austria
Miltenyi Biotec, Bergisch Gladbach, Germany
NatuTec, Frankfurt am Main, Germany
New England Biolabs, Frankfurt am Main, Germany
Novartis Pharma, Vienna, Austria
Octapharma, Lachen, Switzerland
Partec, Görlitz, Germany
PeproTech, Hamburg, Germany
Phadia Austria, Vienna, Austria
Porsche Austria
ProFas, Regensburg, Germany
Charles River Consulting, Sulzfeld, Germany
Roche Austria, Vienna, Austria
R + D Systems, Wiesbaden, Germany
Siemens Medical Solutions Diagnostics, Vienna, Austria
Stallergenes France, Antony Cedex, France
Stemcell Technologies, Grenoble, France
tebu – bio, Offenbach, Germany
THP Medical Products, Vienna, Austria
Werfen Austria, Vienna, Austria
Wiley Blackwell, Weinheim, Germany
Yakult Deutschland, Neuss Germany
*(as per printing date)
Notes
Printed in Austria by: ROBIDRUCK, 1200 Vienna – www.robidruck.co.at
Das Immunglobulin in
seiner natürlichen Form
Natur
weitergeben
Zusammensetzung: 1 ml Intratect® enthält 50 mg Plasmaproteine vom Menschen, davon mind. 96 % IgG (57,2 % IgG1, 37,2 % IgG2, 3,1 % IgG3, 3,0 % IgG4). Höchstgehalt an IgA: 2 mg/ml. Hilfsstoffe: Glycin, Wasser zur
Injektion. Anwendungsgebiete: Substitutionstherapie bei primären Immunmangelsyndromen, sekundärer Hypogammaglobulinämie und rezidivierenden bakteriellen Infektionen bei CLL und multiplem Myelom,
Kinder mit angeborenem AIDS und rezidivierenden Infektionen. Immunmodulation bei ITP bei Kindern oder Erwachsenen mit einem hohen Blutungsrisiko oder vor chirurgischen Eingriffen zur Korrektur der
Thrombozytenzahl, Guillain-Barré-Syndrom und Kawasaki-Syndrom. Allogene Knochenmarktransplantation. Art der Anwendung, Dosierung: Intratect® wird intravenös verabreicht. Dosierung und Intervalle der
Infusionen richten sich nach der Indikation. Gegenanzeigen: Überempfindlichkeit gegen jegliche Bestandteile des Präparates. Überempfindlichkeit gegen homologe Immunglobuline, insbesondere in den sehr
seltenen Fällen von IgA-Mangel, wenn der Patient Antikörper gegen IgA aufweist. Spezielle Hinweise: Bestimmte schwere unerwünschte Nebenwirkungen können im Zusammenhang mit der Infusionsgeschwindigkeit stehen. Es ist die in der Gebrauchsinformation beschriebene Infusionsgeschwindigkeit zu beachten. Die Patienten müssen während der gesamten Dauer der Infusion kontrolliert und auf Symptome unerwünschter Wirkungen beobachtet werden. Bestimmte unerwünschte Nebenwirkungen können bei einer hohen Infusionsgeschwindigkeit häufiger auftreten, bei Patienten mit Hypo- oder Agammaglobulinämie
mit oder ohne IgA-Mangel, bei Patienten, die zum ersten Mal Immunglobulin vom Menschen erhalten oder, in seltenen Fällen, bei einem Wechsel des Immunglobulin-Präparates oder nach einer längeren Behandlungspause. Nebenwirkungen: Gelegentlich können Schüttelfrost, Kopfschmerzen, Fieber, Übelkeit und Erbrechen, allergische Reaktionen, niedriger Blutdruck, Gelenkschmerzen und leichte Rückenschmerzen.
Selten: plötzlicher Blutdruckabfall, vorrübergehende Hautreaktionen, Anstieg des Serumkreatinin-Spiegels, akutes Nierenversagen, thromboembolische Komplikationen. In Einzelfällen: anaphylaktischer Schock,
reversible aseptische Meningitis, reversible hämolytische Anämie/Hämolyse. Wechselwirkungen: Die Gabe von Immunglobulin kann für eine Dauer von mindestens 6 Wochen und bis zu 3 Monaten die Wirksamkeit von attenuierten Lebendimpfstoffen wie Masern-, Röteln-, Mumps- und Windpockenimpfstoffen beeinträchtigen. Nach der Gabe dieses Präparates ist vor der Impfung mit attenuierten Lebendimpfstoffen
eine Wartezeit von 3 Monaten einzuhalten. Bei Masernimpfung kann diese Beeinträchtigung bis zu einem Jahr fortbestehen. Daher sollte bei Patienten, die Masernimpfstoff erhalten, der Antikörperstatus überprüft werden. Handelsformen: Gebrauchsfertige Lösung zur intravenösen Infusion in Durchstichflaschen aus Glas zu 20 ml (1,0 g), 50 ml (2,5 g), 100 ml (5,0 g) und 200 ml (10,0 g).
Biotest Pharma GmbH · Postfach 10 20 40 · D-63266 Dreieich · www.biotest.de
Intratect_DGN.260706.indd 1
01.08.2006 11:41:20 Uhr

final_programme - Österreichische Gesellschaft für Allergologie

Transcription

Similar documents

zur Anwendung von "IVIG bei Polymyositis/Dermatomyositis"

Tak Mak CV _December 2008_ - Institute of Biophysics of

Ärztemagazin - Universitätsspital Basel

PDF - Medizinisches Labor Ostsachsen

PDF

Skript als PDF-File